FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Feitosa, MC
   Leite, PHAD
   Costa, JH
   Hokerberg, YHM
AF Feitosa, Manuella Carvalho
   Amparo da Costa Leite, Pedro Henrique
   Costa, Julia Henrique
   Marques Hokerberg, Yara Hahr
TI Methodological quality assessment of guidelines for surveillance and
   clinical management of dengue and chikungunya
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Practice Guidelines as Topic; Health Evaluation; Arbovirus Infections
ID AGREE II; APPRAISAL; INSTRUMENT; TOOLS; INFECTION
AB The study aimed to assess the methodological quality of guidelines by the Brazilian Ministry of Health, Pan American Health Organization (PAHO), and World Health Organization (WHO) on surveillance and clinical management of dengue and chikungunya. This was a descriptive study in which the tool Appraisal of Guidelines for Research & Evaluation Reporting Checklist II (AGREE II) was applied by four evaluators in independent and masked fashion for six guidelines. Each evaluator assigned a score from 1 (disagree completely) to 7 (agree completely) to the 23 items in the AGREE II domains: scope and purpose; stakeholder involvement; rigor in the development; clarity of presentation; applicability; and editorial independence. The dengue guidelines by PAHO (mean = 5.2, SD = 0.8) and WHO (mean = 4.5, SD = 0.5) obtained the highest overall scores and were recommended with modifications by all the evaluators, while the Brazilian Ministry of Health guidelines (mean = 2.7, SD = 0.4) were not recommended by any of them. Meanwhile, the chikungunya guidelines scored low (means from 22 to 3.0) for all three agencies. The domains with the greatest conformity were "clarity of presentation" (median 84.7%) and "scope and purpose" (77. 1%), while those with the lowest conformity were "editorial independence" (5.2%) and "rigor in development" (9.1%). The study identified gaps in the guidelines' methodological quality, mainly in transparency of the work processes, selection of scientific evidence, and formulation of recommendations, besides lack of clarity in financing and possible conflicts of interest.
C1 [Feitosa, Manuella Carvalho] Univ Fed Roraima, Ctr Ciencias Saude, Av Capitao Ene Garcez 2413, BR-69310000 Boa Vista, Parana, Brazil.
   [Feitosa, Manuella Carvalho; Amparo da Costa Leite, Pedro Henrique] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil.
   [Costa, Julia Henrique; Marques Hokerberg, Yara Hahr] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
RP Feitosa, MC (corresponding author), Univ Fed Roraima, Ctr Ciencias Saude, Av Capitao Ene Garcez 2413, BR-69310000 Boa Vista, Parana, Brazil.
EM manuella.feitosa@ufrr.br
RI hokerberg, yara/K-2880-2016
OI hokerberg, yara/0000-0001-7140-7172; Leite, Pedro Henrique Amparo da
   Costa/0000-0003-4919-8831
CR AGREE Collaboration, AGREE ADV SCI PRACT
   Alonso-Coello P, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2010.042077
   Armstrong JJ, 2017, J CLIN EPIDEMIOL, V81, P13, DOI 10.1016/j.jclinepi.2016.08.005
   Armstrong Melissa J, 2017, Res Involv Engagem, V3, P19, DOI 10.1186/s40900-017-0070-2
   Bhaumik Soumyadeep, 2018, J Evid Based Med, V11, P26, DOI 10.1111/jebm.12285
   Brasil, 2011, DIARIO OFICIAL UNIAO
   Brouwers MC, DEV VALIDITY TESTING
   Brouwers MC, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1152
   Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449
   Brouwers MC, 2010, CAN MED ASSOC J, V182, pE472, DOI 10.1503/cmaj.091716
   Brouwers MC, 2010, CAN MED ASSOC J, V182, P1045, DOI 10.1503/cmaj.091714
   Burda BU, 2014, PUBLIC HEALTH, V128, P444, DOI 10.1016/j.puhe.2014.01.002
   Burls A, 2010, LANCET, V376, P1128, DOI 10.1016/S0140-6736(10)61034-3
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Canelo-Aybar Carlos, 2016, Rev. perú. med. exp. salud publica, V33, P732, DOI 10.17843/rpmesp.2016.334.2559
   Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18
   Comissao Nacional de Incorporacao de Tecnologia no SUS, 2017, PROP PROT CLIN DIR T
   Dans AL, 2010, J CLIN EPIDEMIOL, V63, P1281, DOI 10.1016/j.jclinepi.2010.06.005
   Departamento de Gestao e Incorporacao de Tecnologias em Saude Secretaria de Ciencia Tecnologia e Insumos Estrategicos Ministerio da Saude, 2016, DIR MET EL DIR CLIN
   Departamento de Vigilancia das Doencas Transmissiveis Secretaria de Vigilancia em Saude Ministerio da Saude, 2017, CHIK MAN CLIN
   Dickson C, 2017, SEX TRANSM INFECT, V93, P487, DOI 10.1136/sextrans-2016-052939
   Diretoria Tecnica de Gestao Secretaria de Vigilancia em Saude Ministerio da Saude, 2016, DENG DIAGN MAN CLIN
   Donalisio Maria Rita, 2015, Rev. bras. epidemiol., V18, P283, DOI 10.1590/1980-5497201500010022
   Eikermann Michaela, 2014, BMC Res Notes, V7, P853, DOI 10.1186/1756-0500-7-853
   Fathima AS, 2011, INT J COMPUTER SCI I, V8, P322
   Graham ID, 2000, INT J TECHNOL ASSESS, V16, P1024, DOI 10.1017/S0266462300103095
   Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1
   Hoffmann-Esser W, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2954-8
   Hoffmann-Esser W, 2018, J CLIN EPIDEMIOL, V95, P120, DOI [10.1016/j.clinepi.2017.12.009, 10.1016/j.jclinepi.2017.12.009]
   Hoffmann-Esser W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174831
   Kliner M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1129
   Koh C, 2013, HEPATOLOGY, V58, P2142, DOI 10.1002/hep.26578
   Lytvyn L, 2016, INFECT CONT HOSP EP, V37, P901, DOI 10.1017/ice.2016.104
   Makarski J, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0103-2
   Mathew AJ, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0680-7
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Muller DA, 2017, J INFECT DIS, V215, pS89, DOI 10.1093/infdis/jiw649
   Agbata EN, 2019, J IMMIGR MINOR HEALT, V21, P401, DOI 10.1007/s10903-018-0759-9
   Pan American Health Organization, 2016, DENGUE GUIDELINES PA
   Qaseem A, 2012, ANN INTERN MED, V156, P525, DOI 10.7326/0003-4819-156-7-201204030-00009
   Molino CDRC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166367
   Ronsoni RD, 2015, CAD SAUDE PUBLICA, V31, P1157, DOI 10.1590/0102-311X00118814
   Santamaria R, 2009, INT HEALTH, V1, P133, DOI 10.1016/j.inhe.2009.08.006
   Siering U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082915
   Silva LA, 2017, J CLIN INVEST, V127, P737, DOI 10.1172/JCI84417
   Sinclair D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063715
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Vlayen J, 2005, INT J QUAL HEALTH C, V17, P235, DOI 10.1093/intqhc/mzi027
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   WHO, 2009, GUID PREV CONTR CHIK
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2008, GUID CLIN MAN CHIK F
   Wu Dongbo, 2018, J Evid Based Med, V11, P95, DOI 10.1111/jebm.12293
NR 53
TC 0
Z9 0
U1 0
U2 0
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2020
VL 36
IS 7
AR e00050919
DI 10.1590/0102-311X00050919
PG 14
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA MX5ZJ
UT WOS:000557800600001
PM 32725085
OA DOAJ Gold
DA 2020-11-24
ER

PT J
AU Mata, VE
   de Andrade, CAF
   Passos, SRL
   Hokerberg, YHM
   Fukuoka, LVB
   da Silva, SA
AF Mata, Veronica Elizabeth
   Ferreira de Andrade, Carlos Augusto
   Lambert Passos, Sonia Regina
   Marques Hokerberg, Yara Hahr
   Boas Fukuoka, Levy Vilas
   da Silva, Suzana Alves
TI Rapid immunochromatographic tests for the diagnosis of dengue: a
   systematic review and meta-analysis
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Review
DE Dengue; Diagnosis; Sensitivity and Specificity; Systematic Review;
   Meta-Analysis
ID NS1 ANTIGEN; ZIKA VIRUS; ANTIBODY DETECTION; SUSPECTED DENGUE;
   LABORATORY TESTS; INFECTION; ASSAYS; ACCURACY; IGA; PERFORMANCE
AB Dengue is an important arthropod-borne viral disease in terms of morbidity, mortality, economic impact and challenges in vector control. Benchmarks are expensive, time consuming and require trained personnel. Preventing dengue complications with rapid diagnosis has been based on the testing of easy-to-perform optimized immunochromatographic methods (ICT). This is a systematic meta-analysis review of the diagnostic accuracy of IgA, NS1, IgM and/or IgG ICT studies in suspected cases of acute or convalescent dengue, using a combination of RT-PCR, ELISA NS1, IgM IgG or viral isolation as a reference standard. This protocol was registered in PROSPERO (CRD42014009885). Two pairs of reviewers searched the PubMed, BIREME, Science Direct, Scopus, Web of Science, Ovid MEDLINE JBrigs, SCIRUS and EMBASE databases, selected, extracted, and quality-assessed by QUADAS 2 Of 3,783 studies, we selected 57, of which 40 in meta-analyses according to the analyte tested, with high heterogeneity (I-2 > 90%), as expected for diagnostic tests. We detected higher pooled sensitivity in acute phase IgA (928%) with excellent (90%) specificity. ICT meta-analysis with NS1/IgM/IgG showed 91% sensitivity and 96% specificity. Poorer screening performance was for IgM/IgG ICT (sensitivity = 56%). Thus, the studies with NS1/IgM/IgG ICT showed the best combined performance in the acute phase of the disease.
C1 [Mata, Veronica Elizabeth; Ferreira de Andrade, Carlos Augusto; Lambert Passos, Sonia Regina; Marques Hokerberg, Yara Hahr; Boas Fukuoka, Levy Vilas] Fundacao Oswaldo Cruz, Av Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [da Silva, Suzana Alves] Hosp Coracao, Sao Paulo, Brazil.
RP Mata, VE (corresponding author), Fundacao Oswaldo Cruz, Av Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM veronica.elizabeth.mata@gmail.com
RI ; hokerberg, yara/K-2880-2016
OI Vilas Boas Fukuoka, Levy/0000-0003-0617-9948; hokerberg,
   yara/0000-0001-7140-7172
FU Rio de Janeiro State Research Foundation - FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-25/110.188/2014]; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [221354 E_01/2016];
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [310765/2016-1]; Brazilian National Graduate Studies Board - CAPES
   [001]; Brazilian National Research Council - CNPqNational Council for
   Scientific and Technological Development (CNPq) [401396/2013-4];
   Brazilian Network for Technological and Health Assessment - REBRATS
FX The study received funding from the Brazilian National Research Council
   - CNPq (grant n. 401396/2013-4; Brazilian Network for Technological and
   Health Assessment - REBRATS), and Rio de Janeiro State Research
   Foundation - FAPERJ (grant n. E-25/110.188/2014). Scholarship from
   FAPERJ (grant n. 221354 E_01/2016] to V.E.M. Grant from CNPq (n.
   310765/2016-1) to S.R.L.P. This study was financed in part by the
   Brazilian National Graduate Studies Board - CAPES (Finance Code 001).
CR Ahmed F, 2010, DIAGN MICR INFEC DIS, V68, P339, DOI 10.1016/j.diagmicrobio.2010.07.007
   Aikat Aditi, 2011, J Indian Med Assoc, V109, P543
   Alagarasu K, 2016, EPIDEMIOL INFECT, V144, P876, DOI 10.1017/S0950268815001922
   Andries AC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1551-x
   Andries AC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001993
   [Anonymous], 2020, CAD SAUDE PUBLICA, V36
   Martinez-Vega RA, 2009, BIOMEDICA, V29, P616, DOI 10.7705/biomedica.v29i4.139
   Berry N, 1998, J CLIN MICROBIOL, V36, P2795
   Blacksell SD, 2006, CLIN INFECT DIS, V42, P1127, DOI 10.1086/501358
   Blacksell SD, 2006, T ROY SOC TROP MED H, V100, P775, DOI 10.1016/j.trstmh.2005.10.018
   Blacksell SD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/151967
   Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11
   Branch SL, 1999, CLIN DIAGN LAB IMMUN, V6, P555, DOI 10.1128/CDLI.6.4.555-557.1999
   Buonora SN, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1368-7
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carter MJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003424
   Chaiyaratana W, 2009, DIAGN MICR INFEC DIS, V64, P83, DOI 10.1016/j.diagmicrobio.2009.01.004
   Cohen AL, 2007, TROP MED INT HEALTH, V12, P47, DOI 10.1111/j.1365-3156.2006.01752.x
   Cohen JF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012799
   Colonetti T, 2018, AN ACAD BRAS CIENC, V90, P3147, DOI 10.1590/0001-3765201820170989
   Congpuong K, 2008, ASIAN BIOMED, V2, P289
   da Costa VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094655
   Hernandez SIDC, 2012, DIAGN MICR INFEC DIS, V72, P150, DOI 10.1016/j.diagmicrobio.2011.11.002
   Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dussart P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000280
   Ferraz FO, 2013, J CLIN VIROL, V58, P41, DOI 10.1016/j.jcv.2013.06.015
   Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199
   Gan VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090037
   Garg A, 2019, J LAB PHYS, V11, P63, DOI 10.4103/JLP.JLP_140_18
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360
   Hartono A, 2012, INT J INFECT DIS, V16, pE394, DOI 10.1016/j.ijid.2012.05.522
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Huits R, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofw273
   Hunsperger EA, 2016, J CLIN MICROBIOL, V54, P2090, DOI 10.1128/JCM.00521-16
   Jang WS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213451
   Jusoh TNAM, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/4687182
   Kikuti M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213301
   Krishnananthasivam S, 2015, SE ASIAN J TROP MED, V46, P602
   Kyaw AK, 2019, J VIROL METHODS, V273, DOI 10.1016/j.jviromet.2019.113724
   Passos SRL, 2017, EMERG INFECT DIS, V23, P2120, DOI 10.3201/eid2312.171375
   Lee H, 2019, ANN LAB MED, V39, P566, DOI 10.3343/alm.2019.39.6.566
   Liberati A, 2009, ANN INTERN MED, V151, pW65, DOI [10.1371/journal.pmed.1000100, 10.7326/0003-4819-151-4-200908180-00136]
   Lim JK, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2789-8
   Liu LT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202304
   Lubell Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152420
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Mata VE, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2679-z
   Mitra S, 2014, INT J INFECT DIS, V21, P450, DOI 10.1016/j.ijid.2014.03.1348
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Najioullah F, 2011, DIAGN MICR INFEC DIS, V69, P172, DOI 10.1016/j.diagmicrobio.2010.09.021
   Naz A, 2014, PAK J MED SCI, V30, P166, DOI 10.12669/pjms.301.4173
   Nga TTT, 2007, CLIN VACCINE IMMUNOL, V14, P799, DOI 10.1128/CVI.00483-06
   Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361
   Pal S, 2015, J CLIN MICROBIOL, V53, P1092, DOI 10.1128/JCM.03042-14
   Pal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113411
   Pan-ngum W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050765
   Parham LA, 2014, AM J TROP MED HYG  S, V91, P429
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Pok KY, 2010, VECTOR-BORNE ZOONOT, V10, P1009, DOI 10.1089/vbz.2008.0176
   Prado PS, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170433
   Pun R, 2012, Kathmandu Univ Med J (KUMJ), V10, P7
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Ramirez AH, 2009, DIAGN MICR INFEC DIS, V65, P247, DOI 10.1016/j.diagmicrobio.2009.07.022
   Sanchez-Vargas LA, 2014, DIAGN MICR INFEC DIS, V78, P368, DOI 10.1016/j.diagmicrobio.2013.12.019
   Shih HI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158437
   Shu PY, 2009, CLIN VACCINE IMMUNOL, V16, P589, DOI 10.1128/CVI.00475-08
   Shu PY, 2004, CLIN DIAGN LAB IMMUN, V11, P642, DOI 10.1128/CDLI.11.4.642-650.2004
   Shukla MK, 2017, J MED VIROL, V89, P1146, DOI 10.1002/jmv.24764
   Simonnet C, 2017, EUR J CLIN MICROBIOL, V36, P2441, DOI 10.1007/s10096-017-3083-8
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Tan YY, 2011, J GLOB INFECT DIS, V3, P233, DOI 10.4103/0974-777X.83528
   Tontulawat P, 2011, SE ASIAN J TROP MED, V42, P570
   Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142
   Valdez Sandoval JJ, 2012, REV CUBA MED TROP, V64, P27
   Vickers I, 2017, DIAGN MICR INFEC DIS, V89, P271, DOI 10.1016/j.diagmicrobio.2017.08.019
   Vickers IE, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0164-9
   Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yusuf Noshin Wasim, 2008, J Ayub Med Coll Abbottabad, V20, P26
   Zainah S, 2009, J VIROL METHODS, V155, P157, DOI 10.1016/j.jviromet.2008.10.016
   Zhang H, 2014, INT J INFECT DIS, V26, P57, DOI 10.1016/j.ijid.2014.02.002
NR 84
TC 0
Z9 0
U1 0
U2 0
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2020
VL 36
IS 6
AR e00225618
DI 10.1590/0102-311X00225618
PG 24
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA LZ9RP
UT WOS:000541556400001
PM 32520127
OA DOAJ Gold
DA 2020-11-24
ER

PT J
AU Mata, VE
   Passos, SRL
   dos Santos, MAB
   Buonora, SN
   de Andrade, CAF
   Lima, MDQ
   Costa, BM
   Hokerberg, YHM
AF Mata, Veronica Elizabeth
   Lambert Passos, Sonia Regina
   Borges dos Santos, Maria Angelica
   Buonora, Sibelle Nogueira
   Ferreira de Andrade, Carlos Augusto
   Queiroz Lima, Monique da Rocha
   Costa, Betina Moreira
   Marques Hokerberg, Yara Hahr
TI Diagnostic parameters and reliability of four rapid
   immunochromatographic tests for dengue 4
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Dengue; Immunochromatographic tests; Sensitivity and specificity;
   Reproducibility of tests; Diagnosis
ID NS1 ANTIGEN; ZIKA VIRUS
AB Background: Although performance of rapid immunochromatographic tests (RITs) for dengue virus (DENY) serotypes 1, 2 and 3 is relatively settled, evidence on accuracy of RITs for DENV-4 are based on studies with small sample sizes and with discrepant results.
   Objectives: To assess accuracy and inter-observer agreement of RITs targeting dengue nonstructural protein-1 (NS1) antigen - Dengue NS1-Bioeasy (TM), Dengue NS1 Ag Strip-Bio-Rad (TM), IVB Dengue Ag NS1-Orangelife (TM) and Dengue NS1-K130-Bioclin (TM) in DENV-4 samples.
   Methods: Study sample (n = 324) included adults presenting at an emergency unit in Rio de Janeiro, Brazil, with fever of <= 72 h and two or more dengue symptoms. A serum sample from each patient was tested by each RIT. A positive reverse-transcription polymerase chain reaction was considered as the reference standard for dengue diagnosis. The diagnostic parameters analyzed for each RIT were sensitivity, specificity, positive and negative predictive values, and likelihood ratios. Each RIT was read by homogeneous (two junior nurses) or heterogeneous (one junior nurse and one senior biologist) pairs. Agreement was estimated by simple kappa with 95% confidence interval, positive (Ppos) and negative (Pneg) proportion concordance and prevalence and bias adjusted kappa, rated from poor (k < 0.0) to almost perfect (0.8 < k < 1.0), and perfect (k= 1).
   Results: NS1 RITs for DENV-4 diagnosis showed high specificity (95.9%-99.4%), but low sensitivity (14.7%-45.4%). BioeasyTM had the best performance, with a positive likelihood ratio of 26.0 (95% CI: 8.4;81.0). Inter-observer agreement was almost perfect for all evaluated RITs. Mismatches in confirmed dengue were more common for the BioclinTM (Ppos 88.3-90.0 %) and Orangelife (TM) (Ppos 91.7-94.1 %) tests.
   Conclusions: For DENV-4, the tested RITs had high specificity, but lower sensitivity compared to published results for other serotypes. They should not be used for screening purposes. Different brands may have very different performances. This should be considered upon deciding of using RITs in DENV-4 outbreaks. (C) 2020 Sociedade Brasileira de Infectologia. Published by Elsevier Espana, S.L.U.
C1 [Mata, Veronica Elizabeth; Lambert Passos, Sonia Regina; Buonora, Sibelle Nogueira; Marques Hokerberg, Yara Hahr] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Lab Clin Epidemiol, Rio De Janeiro, RJ, Brazil.
   [Borges dos Santos, Maria Angelica] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth ENSP, Rio De Janeiro, RJ, Brazil.
   [Queiroz Lima, Monique da Rocha] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
   [Ferreira de Andrade, Carlos Augusto; Costa, Betina Moreira] Univ Estacio Sa, Rio De Janeiro, RJ, Brazil.
RP Passos, SRL (corresponding author), Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Lab Clin Epidemiol, Rio De Janeiro, RJ, Brazil.
EM sonia.lambert@ini.fiocruz.br
RI hokerberg, yara/K-2880-2016
OI hokerberg, yara/0000-0001-7140-7172; Buonora,
   Sibelle/0000-0002-0843-1783; Borges dos Santos, Maria
   Angelica/0000-0002-7547-3537
FU Conselho Nacional de Desenvolvimen to Cientifico (CNPq)National Council
   for Scientific and Technological Development (CNPq) [402068/2012-2];
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [3107665/2016-1]; UNESA Produtividade em Pesquisa; FaperjCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [221.354E 01/2016]
FX This study was supported by the Conselho Nacional de Desenvolvimen to
   Cientifico (CNPq) grant numbers. 402068/2012-2. SRLP had a fellowship
   from CNPq [grant number 3107665/2016-1] and UNESA Produtividade em
   Pesquisa. VEM hada doctoral fellowship from Faperj [grant number
   221.354E 01/2016]. The funding source had no involvement in the
   collection, analysis and interpretation of data or in the writing of the
   report.
CR [Anonymous], 2014, MEDCALC STAT SOFTW V
   [Anonymous], 2008, PLATELIA DENGUE NS1
   Martinez-Vega RA, 2009, BIOMEDICA, V29, P616, DOI 10.7705/biomedica.v29i4.139
   Barde PV, 2012, INDIAN J MED RES, V136, P491
   Bio-Rad Laboratories Inc, 2014, DENG NS1 AG STRIP BI
   Blacksell SD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/151967
   Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11
   Buonora SN, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1368-7
   BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V
   Colombo TE, 2013, J CLIN VIROL, V58, P710, DOI 10.1016/j.jcv.2013.10.021
   DUSSART P, 2008, PLOS NEGLECT TROP D, V2, DOI DOI 10.1371/J0URNALTNTD.0000280
   Sea VRF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064056
   Ferraz FO, 2013, J CLIN VIROL, V58, P41, DOI 10.1016/j.jcv.2013.06.015
   Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199
   Gan VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090037
   Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171
   Passos SRL, 2017, EMERG INFECT DIS, V23, P2120, DOI 10.3201/eid2312.171375
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LIMA MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI DOI 10.1371/JOURNALPNTD.0000738
   LOPES N, 2014, REV PAN-AMAZ SAUDE, V5, P55, DOI DOI 10.5123/S2176-62232014000300007
   Low JGH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001191
   MATA VE, 2017, BMC INFECT DIS, V17, DOI DOI 10.1186/S17879-017-7679-Z
   Orangelife comercio e indUstria Ltda. Brazil, 2016, IVB DENG AG NS1 OR
   Osorio L, 2015, MEM I OSWALDO CRUZ, V110, P510, DOI 10.1590/0074-02760140359
   Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361
   Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306
   Pal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113411
   Pok KY, 2010, VECTOR-BORNE ZOONOT, V10, P1009, DOI 10.1089/vbz.2008.0176
   Lima MDQ, 2014, J VIROL METHODS, V204, P105, DOI 10.1016/j.jviromet.2014.02.031
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Quibasa Quimica Basica Ltda Brazil, 2017, DENG NS1 K130 BIOCL
   Ramirez AH, 2009, DIAGN MICR INFEC DIS, V65, P247, DOI 10.1016/j.diagmicrobio.2009.07.022
   Shu PY, 2009, CLIN VACCINE IMMUNOL, V16, P589, DOI 10.1128/CVI.00475-08
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Trajman A, 2008, SCAND J CLIN LAB INV, V68, P77, DOI 10.1080/00365510701666031
   Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142
   Vazquez S, 2010, DIAGN MICR INFEC DIS, V68, P46, DOI 10.1016/j.diagmicrobio.2010.04.006
   Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zhang H, 2014, INT J INFECT DIS, V26, P57, DOI 10.1016/j.ijid.2014.02.002
NR 42
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD JAN-FEB
PY 2020
VL 24
IS 1
BP 58
EP 64
DI 10.1016/j.bjid.2019.12.004
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA LG3SA
UT WOS:000528023500009
PM 31954721
OA DOAJ Gold
DA 2020-11-24
ER

PT J
AU Pone, SM
   Hokerberg, YHM
   Brasil, P
   Nicolai, CCD
   Ferrari, R
   de Oliveira, RDC
AF Pone, Sheila Moura
   Marques Hoekerberg, Yara Hahr
   Brasil, Patricia
   de Araujo Nicolai, Cecilia Carmen
   Ferrari, Rogerio
   Carvalhaes de Oliveira, Raquel de Vasconcellos
TI Socio-demographic inequalities in the clinical characteristics of dengue
   haemorrhagic fever in the city of Rio de Janeiro, Brazil, 2007-2008
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Child; dengue; dengue haemorrhagic fever; spatial analysis
ID NEUROLOGICAL MANIFESTATIONS; CHILDREN; ADULTS; SEVERITY; FEATURES
AB In 2007-2008, the city of Rio de Janeiro underwent an epidemiological change, with increases in the incidence in children and in severe forms of dengue. To describe the clinical profile and spatial distribution of dengue we performed an ecological study based on dengue surveillance data using the Brazilian classification (2005): dengue fever, dengue haemorrhagic fever (DHF) and dengue with complications. chi(2) test was used to describe the clinical and socio-demographic variables (P < 0.05). Spatial distribution of incidence and case-fatality was explored with thematic maps, Moran and Geary indices (P < 0.05). Of the total of 151 527 dengue cases, 38 808 met the inclusion criteria; 42.4% <18 years; 22.9% dengue with complications and 2.7% DHF. Case-fatality was higher in infants (1.4%) and in DHF (7.7%). Bleeding was more frequent in adolescents and adults while plasma leakage was more common in preschoolers and schoolchildren. The highest incidence was found in the West Zone of the city, in a different area from that of the worst case-fatality (P < 0.05). Although the incidence of DHF was higher in schoolchildren, infants showed higher case-fatality. The area with the highest case-fatality did not present the highest incidence, which suggests problems in the organization of health services.
C1 [Pone, Sheila Moura] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Dept Pediat, Rio De Janeiro, Brazil.
   [Marques Hoekerberg, Yara Hahr; Ferrari, Rogerio; Carvalhaes de Oliveira, Raquel de Vasconcellos] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Epidemiol Clin, Rio De Janeiro, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [de Araujo Nicolai, Cecilia Carmen] Secretaria Municipal Saude Rio de Janeiro, Inst Pereira Passos, Rio De Janeiro, Brazil.
RP Hokerberg, YHM (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Epidemiol Clin, Rio De Janeiro, Brazil.
EM yarahahr@ini.fiocruz.br
RI Oliveira, Raquel de V C de/S-7443-2016; hokerberg, yara/K-2880-2016
OI Oliveira, Raquel de V C de/0000-0001-9387-8645; Moura Pone,
   Sheila/0000-0002-6246-8915; hokerberg, yara/0000-0001-7140-7172
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [110.188/2014, E-26/110.964/2013]; Estacio de Sa
   University [1352017]
FX We thank the staff of the Health Department of the Rio de Janeiro city
   who work to improve the quality of the free available databases. This
   work was supported by the Fundacao de Amparo a Pesquisa do Estado do Rio
   de Janeiro - FAPERJ (Grant number 110.188/2014 and E-26/110.964/2013).
   YHMH was supported by Estacio de Sa University (Pesquisa Produtividade
   1352017).
CR Barreto Maurício L., 2008, Estud. av., V22, P53, DOI 10.1590/S0103-40142008000300005
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blanton RE, 2008, EUR J HUM GENET, V16, P762, DOI 10.1038/ejhg.2008.4
   Brazilian Ministry of Health, 2006, SIST INF AGR NOT SIN, V80
   Brazilian Ministry of Health, 2006, PORT N 5 22 FEV 2006
   Brazilian Ministry of Health, 2009, GUIA VIGILANCIA EPID, P816
   Brazilian Ministry of Health, 2005, DENG DIAGN MAN CLIN, P24
   Chen HL, 2008, AM J TROP MED HYG, V79, P495, DOI 10.4269/ajtmh.2008.79.495
   Duarte HHP, 2006, REV SAUDE PUBL, V40, P134, DOI 10.1590/S0034-89102006000100021
   Halsey ES, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001638
   Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007
   Hammond SN, 2005, AM J TROP MED HYG, V73, P1063
   Instituto Brasileiro de Geografia e Estatistica, 2010, CENS 2010
   Joob B, 2014, TRAVEL MED INFECT DI, V12, P195, DOI 10.1016/j.tmaid.2014.02.002
   Kittigul L, 2007, J CLIN VIROL, V39, P76, DOI 10.1016/j.jcv.2007.04.006
   MalhAo TA, 2010, THESIS
   Martinez E, 2005, DENGUE
   Monteiro SP, 2012, MEM I OSWALDO CRUZ, V107, P224, DOI 10.1590/S0074-02762012000200012
   Neeraja M, 2014, ARCH VIROL, V159, P1567, DOI 10.1007/s00705-014-2010-x
   Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110
   R Core Team, 2015, R LANG ENV STAT COMP
   Sabchareon A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001732
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   SPSS Inc, 2007, SPSS WIND VERS 16 0
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Toledo Ana Lucia Araujo de, 2006, Cad. Saúde Pública, V22, P933, DOI 10.1590/S0102-311X2006000500006
   The TD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001679
   United Nations Development Program, 2016, HUMAN DEV REPORT
   Weeratunga PN, 2014, TRAVEL MED INFECT DI, V12, P189, DOI 10.1016/j.tmaid.2013.11.001
   WHO, 1997, DENG HAEM FEV DIAGN, P1
   Wichmann O, 2004, TROP MED INT HEALTH, V9, P1022, DOI 10.1111/j.1365-3156.2004.01295.x
   Witayathawornwong Prasonk, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P896
   World Health Organization (WHO), 2012, HDB CLIN MAN DENG, P111
NR 33
TC 0
Z9 0
U1 0
U2 6
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD FEB
PY 2018
VL 146
IS 3
BP 359
EP 366
DI 10.1017/S0950268817003119
PG 8
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FV7CS
UT WOS:000424741000013
PM 29338803
OA Bronze, Green Published
DA 2020-11-24
ER

PT J
AU de Oliveira, RDC
   Shimakura, SE
   Campos, DP
   Hokerberg, YHM
   Victoriano, FP
   Ribeiro, S
   Veloso, VG
   Grinsztejn, B
   Carvalho, MS
AF Carvalhaes de Oliveira, Raquel de Vasconcellos
   Shimakura, Silvia Emiko
   Campos, Dayse Pereira
   Marques Hokerberg, Yara Hahr
   Victoriano, Flaviana Pavan
   Ribeiro, Sayonara
   Veloso, Valdilea G.
   Grinsztejn, Beatriz
   Carvalho, Marilia Sa
TI Effects of antiretroviral treatment and nadir CD4 count in progression
   to cardiovascular events and related comorbidities in a HIV Brazilian
   cohort: a multi-stage approach
SO AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV
LA English
DT Article
DE Cardiovascular events; progression; HIV/AIDS; multi-stage model; cohort
   study
ID ACUTE MYOCARDIAL-INFARCTION; COMPETING RISKS; DISEASE; INFECTION;
   MODELS; THERAPY; INDIVIDUALS; POPULATION; INHIBITORS; SURVIVAL
AB The use of highly active antiretroviral therapy has resulted in changes of comorbidity profile in people living with HIV (PLHIV), increasing non-AIDS-related events. The occurrence of cardiovascular events is greater in PLHIV, but the mechanism responsible for it is still controversial. This article aimed to investigate factors associated with the progression to cardiovascular events in PLHIV using HAART. A 15-years cohort study with 1135 PLHIV was conducted in Rio de Janeiro-Brazil. Clinical progression was stratified in five states: No comorbidities (s(1)), arterial hypertension (s(2)), lipid abnormalities (s(3)), hypertension and lipid abnormalities (s(4)) and major cardiovascular events (stroke, coronary artery disease, thrombosis or death) (s(5)). Semi-Markov models evaluated the effects of cardiovascular traditional factors, treatment and clinical covariates on transitions between these states. Hazard Ratios (HR) and 95% confidence intervals (CI) were provided. In addition to traditional factors (age, sex, educational level and skin color), the development of one comorbidity (lipid abnormalities or hypertension) increased in patients with low nadir CD4 (<50 cells/mm(3)), (HR=1.59, CI 1.11-2.28 and 1.36, CI 1.11-1.66, respectively). The risk to experience a second comorbidity (s(3)s(4)) increased 75% with low nadir CD4. Age was the only factor that increased the risk of major cardiovascular events once having lipid abnormalities with or without hypertension (s(3),s(4)s(5)). The prolonged use of certain antiretroviral drugs (abacavir, didanosine, ritonavir, lopinavir, amprenavir and fosamprenavir) increased the risk of direct transition (s(1)s(5)) to major cardiovascular events (HR=5.29, CI 1.16-24.05). This analysis suggests that prolonged use of certain antiretroviral drugs led directly to major cardiovascular events, while low nadir CD4 only affected the occurrence of lipid abnormalities and hypertension. Management strategies, including rational use of complex exams (such as, computed-tomography angiography), statins and antihypertensives, should be developed based on the distinct roles of antiretroviral use and of HIV infection itself on the progression to cardiovascular events.
C1 [Carvalhaes de Oliveira, Raquel de Vasconcellos; Campos, Dayse Pereira; Marques Hokerberg, Yara Hahr; Victoriano, Flaviana Pavan; Ribeiro, Sayonara; Veloso, Valdilea G.; Grinsztejn, Beatriz] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, RJ, Brazil.
   [Shimakura, Silvia Emiko] Univ Fed Parana, Setor Ciencias Exatas, Curitiba, Parana, Brazil.
   [Carvalho, Marilia Sa] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, RJ, Brazil.
RP de Oliveira, RDC (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Epidemiol Clin, Ave Brasil 4365, Rio De Janeiro, RJ, Brazil.
EM raquel.vasconcellos@ini.fiocruz.br
RI CARVALHO, MARILIA/AAD-8283-2020; hokerberg, yara/K-2880-2016; Oliveira,
   Raquel de V C de/S-7443-2016
OI CARVALHO, MARILIA/0000-0002-9566-0284; hokerberg,
   yara/0000-0001-7140-7172; Shimakura, Silvia/0000-0002-5468-2516;
   Oliveira, Raquel de V C de/0000-0001-9387-8645
CR Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2
   Andersen PK, 2002, STAT METHODS MED RES, V11, P203, DOI 10.1191/0962280202sm281ra
   Arildsen H, 2013, HIV MED, V14, P1, DOI 10.1111/j.1468-1293.2012.01027.x
   Brasil. Ministerio da Saude, 2008, REC TER ANT AD INF P
   Brignol S, 2015, CAD SAUDE PUBLICA, V31, P1035, DOI 10.1590/0102-311X00178313
   Campos DP, 2005, AIDS, V19, pS22, DOI 10.1097/01.aids.0000191486.92285.1c
   de Oliveira RDC, 2013, CAD SAUDE PUBLICA, V29, P801, DOI 10.1590/S0102-311X2013000400017
   Core Team R, 2015, R LANG ENV STAT COMP
   de Wreede LC, 2011, J STAT SOFTW, V38, P1
   El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283
   Feinstein MJ, 2016, AM J CARDIOL, V117, P214, DOI 10.1016/j.amjcard.2015.10.030
   Foucher Y, 2005, BIOMETRICAL J, V47, P825, DOI 10.1002/bimj.200410170
   Gomo ZAR, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-32
   Albuquerque VMG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-274
   Huzurbazar AV, 2005, FLOWGRAPH MODELS MUL
   Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x
   Josephson F, 2010, J INTERN MED, V268, P530, DOI 10.1111/j.1365-2796.2010.02301.x
   Kousignian I, 2003, JAIDS-J ACQ IMM DEF, V34, P50, DOI 10.1097/00126334-200309010-00007
   Lawless JF, 2015, LIFETIME DATA ANAL, V21, P160, DOI 10.1007/s10985-014-9310-z
   Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816
   Malta M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1530-y
   Martin-Iguacel R, 2015, CURR HIV-AIDS REP, V12, P375, DOI 10.1007/s11904-015-0284-6
   Mathieu E, 2007, METHODOL COMPUT APPL, V9, P389, DOI 10.1007/s11009-007-9033-7
   Nam S, 2016, J CLIN HYPERTENS, V18, P572, DOI 10.1111/jch.12714
   Negredo E, 2010, CLIN INFECT DIS, V50, P1300, DOI 10.1086/651689
   Paisible AL, 2015, JAIDS-J ACQ IMM DEF, V68, P209, DOI 10.1097/QAI.0000000000000419
   Reyskens KMSE, 2014, BBA-MOL BASIS DIS, V1842, P256, DOI 10.1016/j.bbadis.2013.11.019
   Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7
   Santos IS, 2015, ARTERIOSCL THROM VAS, V35, P2054, DOI 10.1161/ATVBAHA.115.305765
   Titman AC, 2010, STAT METHODS MED RES, V19, P621, DOI 10.1177/0962280209105541
   Trevillyan JM, 2015, AIDS, V29, P2309, DOI 10.1097/QAD.0000000000000848
   Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190
   Triant VA, 2012, J INFECT DIS, V205, pS355, DOI 10.1093/infdis/jis195
   Wang SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017326
   World Health Organization, 2006, ANT THER HIV INF AD
   Zanni MV, 2014, AIDS, V28, P2061, DOI 10.1097/QAD.0000000000000360
NR 36
TC 3
Z9 3
U1 0
U2 3
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0954-0121
EI 1360-0451
J9 AIDS CARE
JI Aids Care-Psychol. Socio-Med. Asp. Aids-Hiv
PY 2018
VL 30
IS 5
BP 551
EP 559
DI 10.1080/09540121.2017.1391984
PG 9
WC Health Policy & Services; Public, Environmental & Occupational Health;
   Psychology, Multidisciplinary; Respiratory System; Social Sciences,
   Biomedical
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health; Psychology; Respiratory System; Biomedical Social Sciences
GA GA1QZ
UT WOS:000428093200003
PM 29058481
DA 2020-11-24
ER

PT J
AU Passos, SRL
   dos Santos, MAB
   Cerbino-Neto, J
   Buonora, SN
   Souza, TML
   de Oliveira, RVC
   Vizzoni, A
   Barbosa-Lima, G
   Vieira, YR
   de Lima, MS
   Hokerberg, YHM
AF Lambert Passos, Sonia R.
   Borges dos Santos, Maria A.
   Cerbino-Neto, Jose
   Buonora, Sibelle N.
   Souza, Thiago M. L.
   de Oliveira, Raquel V. C.
   Vizzoni, Alexandre
   Barbosa-Lima, Giselle
   Vieira, Yasmine R.
   de Lima, Marcondes Silva
   Hokerberg, Yara H. M.
TI Detection of Zika Virus in April 2013 Patient Samples, Rio de Janeiro,
   Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID TRANSMISSION; AMERICA
AB We tested 210 dengue virus. negative samples collected from febrile patients during a dengue virus type 4 outbreak in Rio de Janeiro in April 2013 and found 3 samples positive for Zika virus. Our findings support previously published entomological data suggesting Zika virus was introduced into Brazil during October 2012-May 2013.
C1 [Lambert Passos, Sonia R.; Souza, Thiago M. L.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Lambert Passos, Sonia R.; Hokerberg, Yara H. M.] Estacio de Sa Univ, Rio De Janeiro, Brazil.
   [Borges dos Santos, Maria A.] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil.
   [Cerbino-Neto, Jose; Buonora, Sibelle N.; de Oliveira, Raquel V. C.; Vizzoni, Alexandre; Barbosa-Lima, Giselle; Vieira, Yasmine R.; de Lima, Marcondes Silva; Hokerberg, Yara H. M.] Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.
   [Buonora, Sibelle N.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RP Passos, SRL (corresponding author), Evandro Chagas Natl Inst Infect Dis, Clin Epidemiol Lab, Av Brasil 4036 Sala 201 A, BR-21040361 Rio De Janeiro, RJ, Brazil.
EM sonia.lambert@ini.fiocruz.br
RI Neto, Jose Cerbino/P-3713-2018; Vizzoni, Alexandre/W-8718-2019; Lima,
   Marcondes/C-5200-2018; Oliveira, Raquel de V C de/S-7443-2016
OI Neto, Jose Cerbino/0000-0001-9254-917X; Vizzoni,
   Alexandre/0000-0003-0004-5084; Passos, Sonia/0000-0001-9947-2291;
   Buonora, Sibelle/0000-0002-0843-1783; Souza, Thiago/0000-0003-2212-3899;
   Oliveira, Raquel de V C de/0000-0001-9387-8645
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Programa
   de Excelencia em Pesquisa [402068/2012-2]; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq) [310765/2016-1]; Universidade
   Estacio de Sa Pesquisa Produtividade; Universidade Estacio de Sao
   Pesquisa Produtividade; Fundacao de Amparo a Pesquisa do Estado do Rio
   de JaneiroCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ) [E-26/110.188/2014]
FX This work was funded by Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico, Programa de Excelencia em Pesquisa 402068/2012-2.
   S.R.L.P. was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico grant 310765/2016-1 and Universidade Estacio de
   Sa Pesquisa Produtividade. Y.H.M.H. was supported by Universidade
   Estacio de Sao Pesquisa Produtividade and Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro (E-26/110.188/2014). S.R.L.P., M.A.B.S., and
   J.C.N. are members of the Rede Nacional de Especialistas em Zika e
   Doencas Correlatas (the Brazilian National Zika Network).
CR Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Buonora SN, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1368-7
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Massad E, 2017, EPIDEMIOL INFECT, V145, P2303, DOI 10.1017/S0950268817001200
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Freitas ARR, 2016, REV INST MED TROP SP, V58, DOI 10.1590/S1678-9946201658024
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 16
Z9 17
U1 0
U2 0
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD DEC
PY 2017
VL 23
IS 12
BP 2120
EP 2121
DI 10.3201/eid2312.171375
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FO0PA
UT WOS:000416446000040
PM 28953451
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Mata, VE
   Passos, SRL
   Hokerberg, YHM
   Berardinelli, GM
   dos Santos, MAB
   Fukuoka, LVB
   Maciel, ACFSR
   Rodrigues, CDD
   Santos, AD
   de Oliveira, RDC
AF Mata, Vernica Elizabeth
   Lambert Passos, Sonia Regina
   Marques Hokerberg, Yara Hahr
   Berardinelli, Guilherme Migueis
   Borges dos Santos, Maria Angelica
   Boas Fukuoka, Levy Vilas
   Seixas Rangel Maciel, Anna Carolina Fontoura
   dos Santos Rodrigues, Cintia Damasceno
   Santos, Aline da Silva
   Carvalhaes de Oliveira, Raquel de Vasconcellos
TI Accuracy and reliability of an NS1 rapid immunochromatographic test for
   DENV-1 diagnosis at point of care and in the laboratory (vol 17, pg 594,
   2017)
SO BMC INFECTIOUS DISEASES
LA English
DT Correction
AB An error occurred during the publication of the original article [1].
C1 [Mata, Vernica Elizabeth; Lambert Passos, Sonia Regina; Marques Hokerberg, Yara Hahr; Berardinelli, Guilherme Migueis; Boas Fukuoka, Levy Vilas; Seixas Rangel Maciel, Anna Carolina Fontoura; Carvalhaes de Oliveira, Raquel de Vasconcellos] Av Brasil 4036 Sala 201 A, BR-21040361 Rio De Janeiro, RJ, Brazil.
   [Borges dos Santos, Maria Angelica] Rua Leopoldo Bulhoes 1480 Sala 601, BR-21040361 Rio De Janeiro, RJ, Brazil.
   [dos Santos Rodrigues, Cintia Damasceno; Santos, Aline da Silva] Av Brasil 4365, BR-21040360 Rio De Janeiro, RJ, Brazil.
RP Mata, VE (corresponding author), Av Brasil 4036 Sala 201 A, BR-21040361 Rio De Janeiro, RJ, Brazil.
EM veronica.mata@ini.fiocruz.br
OI Passos, Sonia/0000-0001-9947-2291
CR Mata VE, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2679-z
NR 1
TC 0
Z9 0
U1 0
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD NOV 1
PY 2017
VL 17
SU 1
AR 710
DI 10.1186/s12879-017-2804-z
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA FL7AT
UT WOS:000414398700001
PM 29092715
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Mata, VE
   Passos, SRL
   Hokerberg, YHM
   Berardinelli, GM
   dos Santos, MAB
   Fukuoka, LVB
   Maciel, ACFSR
   Rodrigues, CDD
   Santos, AD
   de Oliveira, RDC
AF Mata, Veronica Elizabeth
   Lambert Passos, Sonia Regina
   Marques Hokerberg, Yara Hahr
   Berardinelli, Guilherme Migueis
   Borges dos Santos, Maria Angelica
   Boas Fukuoka, Levy Vilas
   Seixas Rangel Maciel, Anna Carolina Fontoura
   dos Santos Rodrigues, Cintia Damasceno
   Santos, Aline da Silva
   Carvalhaes de Oliveira, Raquel de Vasconcellos
TI Accuracy and reliability of an NS1 rapid immunochromatographic test for
   DENV-1 diagnosis at the point of care and in the laboratory
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Dengue; Sensitivity and specificity; Diagnosis; Point-of-care systems;
   NS1; Reproducibility of results
ID DENGUE DIAGNOSIS; SPECIFICITY; ANTIGEN
AB Background: Rapid immunochromatographic tests (ICT) for dengue non-structural protein 1 (NS1) have shown good performance for diagnosing acute-phase dengue in serum in laboratory settings, but rarely have been assessed in whole blood and at point of care (POC). This study compare the accuracy and inter-and intra-observer reliability of the NS1 Bioeasy(TM) ICT in whole blood at POC versus serum in the laboratory, during a DENV-1 epidemic.
   Methods: Cross-sectional study involving 144 adults spontaneously demanding care in an emergency department within 4 days of onset of acute febrile illness. Accuracy of NS1 Bioeasy (TM) ICT was compared in whole blood and serum, both at 15 and 30 min, blinded to the reference RT-PCR or NS1 ELISA. Non-dengue patients were also tested for Zika virus with RT-PCR. Reliability of whole blood and serum readings by the same or different observers was measured by simple kappa (95% CI).
   Results: At 15 min, sensitivity (Sn) of NS1 Bioeasy (TM) ICT in whole blood/POC was 76.7% (95% CI: 68.0-84.1) and specificity (Sp) was 87.0% (95% CI: 66.4-97.2). Sn in serum/ laboratory was 82% (95% CI: 74.1-88.6) and Sp 100% (95% CI: 85.8-100). Positive likelihood ratio was 5.9 (95% CI: 2.0-17.0) for whole blood/POC and 19.8 (95% CI: 2.9-135.1) for serum/ laboratory. Reliability of matched readings of whole blood/POC and serum/ laboratory by the same observer (k = 0.83, 95% CI: 0.74-0.93) or different observers (k = 0.81, 95% CI: 0.72-0.92) was almost perfect, with higher discordant levels in the absence of dengue. Results did not differ statistically at 5%.
   Conclusions: NS1 Bioeasy (TM) ICT in DENV-1 epidemics is a potentially confirmatory test. Invalid results at 15 min should be reread at 30 min. To optimize impact of implementing ICT in the management of false-negatives it should be incorporated into an algorithm according to setting and available specimen.
C1 [Mata, Veronica Elizabeth; Lambert Passos, Sonia Regina; Marques Hokerberg, Yara Hahr; Berardinelli, Guilherme Migueis; Boas Fukuoka, Levy Vilas; Seixas Rangel Maciel, Anna Carolina Fontoura; Carvalhaes de Oliveira, Raquel de Vasconcellos] Av Brasil 4036 Sala 201 A, BR-21040361 Rio De Janeiro, RJ, Brazil.
   [Borges dos Santos, Maria Angelica] Rua Leopoldo Bulhoes 1480 Sala 601, BR-21040361 Rio De Janeiro, RJ, Brazil.
   [dos Santos Rodrigues, Cintia Damasceno; Santos, Aline da Silva] Av Brasil 4365, BR-21040360 Rio De Janeiro, RJ, Brazil.
RP Mata, VE (corresponding author), Av Brasil 4036 Sala 201 A, BR-21040361 Rio De Janeiro, RJ, Brazil.
EM veronica.mata@ini.fiocruz.br
OI Passos, Sonia/0000-0001-9947-2291
CR Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1
   Andries AC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001993
   [Anonymous], 2014, MEDCALC STAT SOFTW V
   [Anonymous], 2015, DENG ED TEST BIOEAS
   [Anonymous], 2016, IVB DENG AG NS1 ORAN
   [Anonymous], 2012, SER EL CLASS DENG VI
   [Anonymous], 2008, PLAT DENG NS1 AG
   Martinez-Vega RA, 2009, BIOMEDICA, V29, P616, DOI 10.7705/biomedica.v29i4.139
   Buonora SN, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1368-7
   BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V
   Constenla Dagna, 2015, Value Health Reg Issues, V8, P80, DOI 10.1016/j.vhri.2015.06.001
   Dussart P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000280
   FAGAN TJ, 1975, NEW ENGL J MED, V293, P257
   Ferraz FO, 2013, J CLIN VIROL, V58, P41, DOI 10.1016/j.jcv.2013.06.015
   Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199
   Gan VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090037
   Goodman C, 2005, ADV MED
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360
   Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171
   Korevaar DA, 2015, RADIOLOGY, V274, P781, DOI 10.1148/radiol.14141160
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Matheus S, 2016, EMERG INFECT DIS, V22, P1691, DOI 10.3201/eid2209.160725
   Organizacao Mundial da Saude, 2009, DENG DIR DIAGN TRAT, P11
   Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361
   Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306
   Pal S, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-23
   Palamountain KM, 2012, J INFECT DIS, V205, pS181, DOI 10.1093/infdis/jis203
   Peeling RW, 2010, CLIN MICROBIOL INFEC, V16, P1062, DOI 10.1111/j.1469-0691.2010.03279.x
   Pok KY, 2010, VECTOR-BORNE ZOONOT, V10, P1009, DOI 10.1089/vbz.2008.0176
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   R Core Team, 2015, R ID AMB COMP EST
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Trajman A, 2007, SCAND J CLIN LAB INV, V68, P77
   Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142
NR 37
TC 5
Z9 5
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD AUG 29
PY 2017
VL 17
AR 594
DI 10.1186/s12879-017-2679-z
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA FF2IH
UT WOS:000408720600002
PM 28851293
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Cabral, VP
   de Andrade, CAF
   Passos, SRL
   Martins, MDM
   Hokerberg, YHM
AF Cabral, Vanderlea Poeys
   Ferreira de Andrade, Carlos Augusto
   Lambert Passos, Sonia Regina
   Moreira Martins, Maria de Fatima
   Marques Hoekerberg, Yara Hahr
TI Severe infection in patients with rheumatoid arthritis taking anakinra,
   rituximab, or abatacept: a systematic review of observational studies
SO REVISTA BRASILEIRA DE REUMATOLOGIA
LA English
DT Review
DE Rheumatoid arthritis/therapy; Antirheumatic drugs/adverse effects;
   Infection; Biological therapy/adverse effects; Review of literature as
   topic
ID COSTIMULATION MODULATOR ABATACEPT; DOUBLE-BLIND; ANTIRHEUMATIC DRUGS;
   PHASE IIB; SAFETY; EFFICACY; RISK; BIOLOGICS
AB A question is raised about an increased risk of severe infection from the use of biological drugs in patients with rheumatoid arthritis. This systematic review of observational studies aimed at assessing the risk of severe infection associated with the use of anakinra, rituximab, and abatacept in patients with rheumatoid arthritis. The following databases were searched: PubMed, Science Direct, Scopus, Web of Knowledge, Scirus, Cochrane, Exerpta Medica Database, Scielo, and Lilacs up to July 2010. Severe infections were defined as those life-threatening ones in need of the use of parenteral antibiotics or of hospitalization. Longitudinal observational studies were selected without language restriction, involving adult patients diagnosed with rheumatoid arthritis and who used anakinra, rituximab, or abatacept. In four studies related to anakinra, 129 (5.1%) severe infections were related in 2,896 patients, of which three died. With respect to rituximab, two studies reported 72 (5.9%) severe infections in 1,224 patients, of which two died. Abatacept was evaluated in only one study in which 25 (2.4%) severe infections were reported in 1046 patients. The main site of infection for these three drugs was the respiratory tract. One possible explanation for the high frequency of severe infections associated with anakinra may be the longer follow-up time in the selected studies. The high frequency of severe infections associated with rituximab could be credited to the less strict inclusion criteria for the patients studied. Therefore, infection monitoring should be cautious in patients with rheumatoid arthritis in use of these three drugs. (C) 2016 Published by Elsevier Editora Ltda.
C1 [Cabral, Vanderlea Poeys] Fundacao Oswaldo Cruz Fiocruz, Comissao Controle Infeccao Hosp, Inst Nacl Infectol Evandro Chagas INI, Rio De Janeiro, RJ, Brazil.
   [Ferreira de Andrade, Carlos Augusto; Lambert Passos, Sonia Regina; Marques Hoekerberg, Yara Hahr] Fundacao Oswaldo Cruz Fiocruz, Lab Epidemiol Clin, Inst Nacl Infectol Evandro Chagas INI, Rio De Janeiro, RJ, Brazil.
   [Moreira Martins, Maria de Fatima] Fundacao Oswaldo Cruz Fiocruz, Inst Comunicacao & Informacao Cient & Tecnol Saud, Rio De Janeiro, RJ, Brazil.
RP de Andrade, CAF (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Lab Epidemiol Clin, Inst Nacl Infectol Evandro Chagas INI, Rio De Janeiro, RJ, Brazil.
EM carlosandrade07@gmail.com
OI Passos, Sonia/0000-0001-9947-2291
FU Instituto Nacional de Infectologia Evandro Chagas, Fundacao Oswaldo Cruz
FX Instituto Nacional de Infectologia Evandro Chagas, Fundacao Oswaldo
   Cruz.
CR Alamanos Y, 2006, SEMIN ARTHRITIS RHEU, V36, P182, DOI 10.1016/j.semarthrit.2006.08.006
   Alonso-Ruiz A, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-52
   Bernatsky S, 2010, J RHEUMATOL, V37, P928, DOI 10.3899/jrheum.091107
   Bertolo MB, 2007, REV BRAS REUMATOL, V47, P151
   Brassard P, 2006, CLIN INFECT DIS, V43, P717, DOI 10.1086/506935
   Cohen SB, 2004, ANN RHEUM DIS, V63, P1062, DOI 10.1136/ard.2003.016014
   Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025
   Curtis JR, 2014, ARTHRIT CARE RES, V66, P990, DOI 10.1002/acr.22281
   Emery P, 2006, ARTHRITIS RHEUM, V54, P1390, DOI 10.1002/art.21778
   Fleischmann RM, 2006, ANN RHEUM DIS, V65, P1006, DOI 10.1136/ard.2005.048371
   Gartlehner G, 2006, J RHEUMATOL, V33, P2398
   Genovese MC, 2009, ANN RHEUM DIS, V68, P1894, DOI 10.1136/ard.2008.101675
   Keystone E, 2007, ARTHRITIS RHEUM-US, V56, P3896, DOI 10.1002/art.23059
   Kremer JM, 2005, ARTHRITIS RHEUM, V52, P2263, DOI 10.1002/art.21201
   Listing J, 2005, ARTHRITIS RHEUM-US, V52, P3403, DOI 10.1002/art.21386
   Meyboom RHB, 1999, DRUG SAFETY, V21, P429, DOI 10.2165/00002018-199921060-00001
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535]
   Moreland LW, 2002, ARTHRITIS RHEUM, V46, P1470, DOI 10.1002/art.10294
   Nuki G, 2002, ARTHRITIS RHEUM, V46, P2838, DOI 10.1002/art.10578
   Ramiro S, 2014, ANN RHEUM DIS, V73, P529, DOI 10.1136/annrheumdis-2013-204575
   Salliot C, 2009, ANN RHEUM DIS, V68, P25, DOI 10.1136/ard.2007.083188
   Schiff M, 2009, ANN RHEUM DIS, V68, P1708, DOI 10.1136/ard.2008.099218
   Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4
   Singh JA, 2015, LANCET, V386, P258, DOI 10.1016/S0140-6736(14)61704-9
   Storage Steven S., 2010, Korean Journal of Internal Medicine, V25, P1, DOI 10.3904/kjim.2010.25.1.1
   Weinblatt M, 2006, ARTHRITIS RHEUM, V54, P2807, DOI 10.1002/art.22070
   Wells G, NEWCASTLE OTTAWA SCA
NR 27
TC 20
Z9 20
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0482-5004
J9 REV BRAS REUMATOL
JI Rev. Bras. Reumatol.
PD NOV-DEC
PY 2016
VL 56
IS 6
BP 543
EP 550
DI 10.1016/j.rbre.2016.10.001
PG 8
WC Rheumatology
SC Rheumatology
GA EE4CG
UT WOS:000389548800012
PM 27914602
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Correa, LS
   Hokerberg, YHM
   de Vasconcellos, R
   de Oliveira, C
   Berms, DMD
   Alexandria, HAF
   Daumas, RP
   de Andrade, CAF
   Passos, SRL
   Brasi, P
AF Correa, Luana Sicuro
   Marques Hokerberg, Yara Hahr
   de Vasconcellos, Raquel
   de Oliveira, Carvalhaes
   de Souza Berms, Danielle Martins
   Ferreira Alexandria, Helenara Abadia
   Daumas, Regina Paiva
   Ferreira de Andrade, Carlos Augusto
   Lambert Passos, Sonia Regina
   Brasi, Patricia
TI Use of Warning Signs for Dengue by Pediatric Health Care Staff in Brazil
SO PLOS ONE
LA English
DT Article
ID HEMORRHAGIC-FEVER; RISK-FACTORS; CULTURAL-ADAPTATION; CASE
   CLASSIFICATION; CLINICAL-FEATURES; SHOCK SYNDROME; PUERTO-RICO;
   CHILDREN; DISEASE; INFECTION
AB Objective
   The aim of this study was to describe the use of dengue warning signs by pediatric health-care staff in the Brazilian public health care system.
   Methods
   Cross-sectional study (2012) with physicians, nurses, and nurse technicians assisting children in five health care facilities. Participants reported the use and importance of dengue warning signs in pediatrics clinical practice through a structured questionnaire. Differences in the use of signs (chi-square test) and in the ranking assigned to each of them (Kruskal-Wallis) were assessed according to health care occupation and level of care (p<0.05).
   Results
   The final sample comprised 474 participants (97%), mean age of 37 years (standard deviation = 10.3), mainly females (83.8%), physicians (40.1%) and from tertiary care (75.1%). The majority (91%) reported using warning signs for dengue in pediatrics clinical practice. The most widely used and highly valued signs were major hemorrhages (gastrointestinal, urinary), abdominal pain, and increase in hematocrit concurrent or not with rapid decrease in platelet count. Persistent vomiting as well as other signs of plasma leakage such as respiratory distress and lethargy/restlessness were not identified as having the same degree of importance, especially by nurse technicians and in primary or secondary care.
   Discussion
   Although most health care staff reported using dengue warning signs, it would be useful to extend the training for identifying easily recognizable signs of plasma leakage that occur regardless of bleeding.
C1 [Correa, Luana Sicuro; de Souza Berms, Danielle Martins] Univ Estado Rio De Janeiro, Dept Pediat, Rio De Janeiro, RJ, Brazil.
   [Marques Hokerberg, Yara Hahr; de Vasconcellos, Raquel; Ferreira de Andrade, Carlos Augusto; Lambert Passos, Sonia Regina] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Lab Clin Epidemiol, Rio De Janeiro, RJ, Brazil.
   [Correa, Luana Sicuro; Marques Hokerberg, Yara Hahr] Univ Estacio Sa, Sch Med, Rio De Janeiro, RJ, Brazil.
   [Ferreira Alexandria, Helenara Abadia] Univ Estado Rio De Janeiro, Dept Obstet & Gynecol, Rio De Janeiro, RJ, Brazil.
   [Daumas, Regina Paiva] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Germano Sinval Faria Teaching Primary Care Ctr, Rio De Janeiro, RJ, Brazil.
   [Brasi, Patricia] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, Rio De Janeiro, RJ, Brazil.
RP Correa, LS (corresponding author), Univ Estado Rio De Janeiro, Dept Pediat, Rio De Janeiro, RJ, Brazil.; Correa, LS (corresponding author), Univ Estacio Sa, Sch Med, Rio De Janeiro, RJ, Brazil.
EM luanascorrea@gmail.com
RI DAUMAS, REGINA/M-9387-2013; Oliveira, Raquel de V C de/S-7443-2016
OI DAUMAS, REGINA/0000-0002-8923-7711; Passos, Sonia/0000-0001-9947-2291;
   Oliveira, Raquel de V C de/0000-0001-9387-8645
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [110.188/2014, E-26/110.964/2013]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico CNPqNational Council for
   Scientific and Technological Development (CNPq) [311414/2013-3]; Rede
   Dengue Fiocruz
FX This work was funded by the Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro - FAPERJ (Grant number 110.188/2014 and
   E-26/110.964/2013). SRLP was supported by Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico CNPq (311414/2013-3), and PB by
   Rede Dengue Fiocruz. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abeywardana S, 2012, CEYLON MED J, V57, P177, DOI 10.4038/cmj.v57i4.5091
   Alexander N, 2011, TROP MED INT HEALTH, V16, P936, DOI 10.1111/j.1365-3156.2011.02793.x
   Arora Shilpa Khanna, 2012, J Neurosci Rural Pract, V3, P228, DOI 10.4103/0976-3147.98267
   Balasubramanian S, 2012, ARCH DIS CHILD, V97, P907, DOI 10.1136/archdischild-2012-301710
   Balmaseda A, 2005, AM J TROP MED HYG, V73, P1059, DOI 10.4269/ajtmh.2005.73.1059
   Barniol J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-106
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biswas HH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001562
   Brasil Ministerio da Saude Secretaria de Vigilancia em Saude, 2007, DENG DIAGN MAN CLIN
   Brasil Ministerio da Saude Secretaria de Vigilancia em Saude, DIR TECN DENG DIAGN
   Correa LS, 2015, CAD SAUDE PUBLICA, V31, P247, DOI 10.1590/0102-311X00213913
   da Silva GM, 2009, REV BRAS ENFERM, V62, P362, DOI 10.1590/S0034-71672009000300005
   Cavalcanti LPD, 2010, REV SOC BRAS MED TRO, V43, P355, DOI 10.1590/S0037-86822010000400003
   Ferreira JCDA, 2009, ACTA PAUL ENFERM, V22, P31, DOI 10.1590/S0103-21002009000100005
   Figueiro AC, 2011, CAD SAUDE PUBLICA, V27, P2373, DOI 10.1590/S0102-311X2011001200009
   Giraldo D, 2011, T ROY SOC TROP MED H, V105, P601, DOI 10.1016/j.trstmh.2011.07.007
   Gupta V, 2011, J TROP PEDIATRICS, V57, P451, DOI 10.1093/tropej/fmr020
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   Halstead Scott B, 2009, F1000 Med Rep, V1, DOI 10.3410/M1-73
   Hammond SN, 2005, AM J TROP MED HYG, V73, P1063
   Herdman M, 1998, QUAL LIFE RES, V7, P323, DOI 10.1023/A:1024985930536
   Ho TS, 2013, J FORMOS MED ASSOC, V112, P18, DOI 10.1016/j.jfma.2012.11.004
   Horstick O, 2014, AM J TROP MED HYG, V91, P621, DOI 10.4269/ajtmh.13-0676
   Kalayanarooj Siripen, 2011, Trop Med Health, V39, P83, DOI 10.2149/tmh.2011-S10
   Kanade T, 2011, J VECTOR DIS, V48, P180
   Kularatne Sam, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1198
   Lee LK, 2011, ANN ACAD MED SINGAP, V40, P533
   Martinez E, 2005, DENGUE
   Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397
   Potts JA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000769
   Rigau-Perez JG, 2006, CLIN INFECT DIS, V42, P1241, DOI 10.1086/501355
   Rottingen JA, 2013, LANCET, V382, P1286, DOI 10.1016/S0140-6736(13)61046-6
   Shah I, 2004, J TROP PEDIATRICS, V50, P301, DOI 10.1093/tropej/50.5.301
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Srikiatkhachorn A, 2010, CLIN INFECT DIS, V50, P1135, DOI 10.1086/651268
   Tantracheewathorn Taweewong, 2007, Journal of the Medical Association of Thailand, V90, P272
   Tomashek KM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001614
   Tran NBC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000657
   The TD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001679
   WHO, 2009, WHO TECH REP SER, V958, P1
   WHO, 1997, DENG HAEM FEV DIAGN, P1
   Wichmann O, 2004, TROP MED INT HEALTH, V9, P1022, DOI 10.1111/j.1365-3156.2004.01295.x
   Ximenes Neto FRG, 2008, NURSING ASSISTANTS T, P51
NR 43
TC 1
Z9 1
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 7
PY 2016
VL 11
IS 10
AR e0163946
DI 10.1371/journal.pone.0163946
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DZ2UW
UT WOS:000385698100013
PM 27716812
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Pone, SM
   Hokerberg, YHM
   de Oliveira, RDC
   Daumas, RP
   Pone, TM
   Pone, MVD
   Brasil, P
AF Pone, Sheila Moura
   Marques Hokerberg, Yara Hahr
   Carvalhaes de Oliveira, Raquel de Vasconcellos
   Daumas, Regina Paiva
   Pone, Tamiris Moura
   da Silva Pone, Marcos Vinicius
   Brasil, Patricia
TI Clinical and laboratory signs associated to serious dengue disease in
   hospitalized children
SO JORNAL DE PEDIATRIA
LA English
DT Article
DE Dengue; Children; Sensitivity and specificity; Validation studies
ID SHOCK SYNDROME; HEMORRHAGIC-FEVER; RISK-FACTORS; CLASSIFICATION;
   SEVERITY; ACCURACY; ILLNESS
AB Objective: To evaluate the validity of clinical and laboratory signs to serious dengue disease in hospitalized children.
   Methods: Retrospective cohort of children (<18 years) hospitalized with dengue diagnosis (2007-2008). Serious dengue disease was defined as death or use of advanced life support therapy. Accuracy measures and area under the receiver operating characteristic curve were calculated.
   Results: Of the total (n=145), 53.1% were female, 69% aged 2-11 years, and 15.9% evolved to the worse outcome. Lethargy had the best accuracy (positive likelihood ratio >19 and negative likelihood ratio <0.6). Pleural effusion and abdominal distension had higher sensitivity (82.6%). History of bleeding (epistaxis, gingival or gastrointestinal bleeding) and severe hemorrhage (pulmonary or gastrointestinal bleeding) in physical examination were more frequent in serious dengue disease (p < 0.01), but with poor accuracy (positive likelihood ratio = 1.89 and 3.89; negative likelihood ratio = 0.53 and 0.60, respectively). Serum albumin was lower in serious dengue forms (p < 0.01). Despite statistical significance (p < 0.05), both groups presented thrombocytopenia. Platelets count, hematocrit, and hemoglobin parameters had area under the curve <0.5.
   Conclusions: Lethargy, abdominal distension, pleural effusion, and hypoalbuminemia were the best clinical and laboratorial markers of serious dengue disease in hospitalized children, while bleeding, severe hemorrhage, hemoconcentration and thrombocytopenia did not reach adequate diagnostic accuracy. In pediatric referral hospitals, the absence of hemoconcentration does not imply absence of plasma leakage, particularly in children with previous fluid replacement. These findings may contribute to the clinical management of dengue in children at referral hospitals. (C) 2016 Published by Elsevier Editora Ltda. on behalf of Sociedade Brasileira de Pediatria.
C1 [Pone, Sheila Moura; Marques Hokerberg, Yara Hahr; Carvalhaes de Oliveira, Raquel de Vasconcellos; Daumas, Regina Paiva; Pone, Tamiris Moura; da Silva Pone, Marcos Vinicius; Brasil, Patricia] Fundacao Oswaldo Cruz Fiocruz, Rio De Janeiro, RJ, Brazil.
RP Pone, SM (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Rio De Janeiro, RJ, Brazil.
EM spone@iff.fiocruz.br
RI DAUMAS, REGINA/M-9387-2013; da Silva Pone, Marcos Vinicius/N-1285-2019;
   Oliveira, Raquel de V C de/S-7443-2016
OI DAUMAS, REGINA/0000-0002-8923-7711; Oliveira, Raquel de V C
   de/0000-0001-9387-8645; Moura Pone, Sheila/0000-0002-6246-8915; da Silva
   Pone, Marcos Vinicius/0000-0002-5152-2242
FU Rede Dengue FIOCRUZ; Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro - FAPERJCarlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ) [E-26/110.964/2013 - APQ1]
FX This research was supported by Rede Dengue FIOCRUZ and Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ [grant number
   E-26/110.964/2013 - APQ1].
CR Balmaseda A, 2005, AM J TROP MED HYG, V73, P1059, DOI 10.4269/ajtmh.2005.73.1059
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41
   Brasil. Ministerio da Saude Secretaria de Vigilancia em Saude, 2005, GUIA VIGILANCIA EPID
   Brasil. Ministerio da Saude Secretaria de Vigilancia em Saude, 2013, DIR TECN GEST DENG D
   Capeding RZ, 2010, AM J TROP MED HYG, V82, P330, DOI 10.4269/ajtmh.2010.09-0542
   Elling R, 2013, PEDIATR INFECT DIS J, V32, P1020, DOI 10.1097/INF.0b013e31829fd0e9
   Giraldo D, 2011, T ROY SOC TROP MED H, V105, P601, DOI 10.1016/j.trstmh.2011.07.007
   Gupta P, 2010, J INFECT DEV COUNTR, V4, P150, DOI 10.3855/jidc.708
   Gutierrez G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002385
   Halstead S. B., 2009, F1000 MED REP, V1, P73
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   Halstead SB, 2012, PAEDIATR INT CHILD H, V32, P5, DOI 10.1179/2046904712Z.00000000045
   Horstick O, 2012, PATHOG GLOB HEALTH, V106, P94, DOI 10.1179/2047773212Y.0000000017
   Khan E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012505
   Kittigul L, 2007, J CLIN VIROL, V39, P76, DOI 10.1016/j.jcv.2007.04.006
   Kohn MA, 2013, ACAD EMERG MED, V20, P1194, DOI 10.1111/acem.12255
   Lora AJM, 2014, AM J TROP MED HYG, V90, P169, DOI 10.4269/ajtmh.13-0440
   Malavige GN, 2006, ARCH DIS CHILD, V91, P396, DOI 10.1136/adc.2005.085191
   Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412
   Neto RDP, 2013, REV SOC BRAS MED TRO, V46, P765, DOI 10.1590/0037-8682-1716-2013
   Pongpan S, 2013, ISRN PEDIAT, DOI DOI 10.1155/2013/845876
   Potts JA, 2010, AM J TROP MED HYG, V83, P781, DOI 10.4269/ajtmh.2010.10-0135
   Potts JA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000769
   Tanner L, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000196
   Tantracheewathorn Taweewong, 2007, Journal of the Medical Association of Thailand, V90, P272
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Thein S, 1997, AM J TROP MED HYG, V56, P566, DOI 10.4269/ajtmh.1997.56.566
   Witayathawornwong Prasonk, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P896
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 30
TC 10
Z9 11
U1 0
U2 4
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD SEP-OCT
PY 2016
VL 92
IS 5
BP 464
EP 471
DI 10.1016/j.jped.2015.12.005
PG 8
WC Pediatrics
SC Pediatrics
GA EA3VN
UT WOS:000386537500005
PM 27112034
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Arrue, AM
   Neves, ET
   Magnago, TSBD
   Cabral, IE
   da Gama, SGN
   Hokerberg, YHM
AF Arrue, Andrea Moreira
   Neves, Eliane Tatsch
   Bosi de Souza Magnago, Tania Solange
   Cabral, Ivone Evangelista
   Nogueira da Gama, Silvana Granado
   Marques Hokerberg, Yara Hahr
TI Translation and adaptation of the Children with Special Health Care
   Needs Screener to Brazilian Portuguese
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Translating; Reproducibility of Results; Comprehensive Health Care;
   Child
ID AGREEMENT; VALIDITY
AB This study aimed to elaborate the Brazilian version of the Children with Special Health Care Needs Screener to assess internal consistency and inter-observer agreement. The stages included translation, back-translation, expert committee review, and pretest. Participation included 140 family members of children 0-12 years of age at health services in southern Brazil. Reliability was assessed with kappa statistic and Cronbach's alpha. In the assessment of clarity with health professionals, 80% rated the questions very clear. Prevalence of children with special health needs was 36%. Mean time for applying the instrument was 3.5 minutes. The process identified difficulties in understanding question number two. The instrument showed satisfactory internal consistency and perfect agreement. Future research should add to the psychometric analyses of the instrument's adequacy for the Brazilian context, thereby contributing to a standardized definition of this young age group's epidemiological profile within the public health scenario in Brazil.
C1 [Arrue, Andrea Moreira; Nogueira da Gama, Silvana Granado] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil.
   [Neves, Eliane Tatsch; Bosi de Souza Magnago, Tania Solange] Univ Fed Santa Maria, Santa Maria, RS, Brazil.
   [Cabral, Ivone Evangelista] Univ Fed Rio de Janeiro, Escola Enfermagem Anna Nery, Rio De Janeiro, Brazil.
   [Marques Hokerberg, Yara Hahr] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
RP Arrue, AM (corresponding author), Rua Toledo Piza 37, BR-27253250 Volta Redonda, RJ, Brazil.
EM andrea.ensp@gmail.com
CR Bethel CD, 2015, ACAD PEDIATR, V15, P165, DOI 10.1016/j.acap.2014.10.003
   Cabral I. E., 2003, ESC ANNA NERY, V7, P211
   Cade AC, 2011, ACAD PEDIATR, V11, P128, DOI 10.1016/j.acap.2009.11.006
   Child and Adolescent Health Measurement Initiative, 2015, CHILDR SPEC HLTH CAR
   Child and Adolescent Health Measurement Initiative, CHILDR SPEC HLTH CAR
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Goldfeld S, 2012, J DEV BEHAV PEDIATR, V33, P319, DOI 10.1097/DBP.0b013e31824a7b8e
   GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   McPherson M, 1998, PEDIATRICS, V102, P137, DOI 10.1542/peds.102.1.137
   Neves ET, 2013, PROENF SAUDE CRIANCA, V7, P53
   Pasquali L, 1999, INSTRUMENTOS PSICOLO
   Read D, 2007, MATERN CHILD HLTH J, V11, P568, DOI 10.1007/s10995-007-0207-2
   Reichenheim ME, 2014, CAD SAUDE PUBLICA, V30, P927, DOI 10.1590/0102-311X00143613
NR 14
TC 9
Z9 9
U1 0
U2 2
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD JUN
PY 2016
VL 32
IS 6
AR e00130215
DI 10.1590/0102-311X00130215
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DP6RS
UT WOS:000378626800009
PM 27333143
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Buonora, SN
   Passos, SRL
   do Carmo, CN
   Quintela, FM
   de Oliveira, DNR
   dos Santos, FB
   Hokerberg, YHM
   Nogueira, RMR
   Daumas, RP
AF Buonora, Sibelle Nogueira
   Lambert Passos, Sonia Regina
   do Carmo, Cleber Nascimento
   Quintela, Fernanda Moises
   Rodrigues de Oliveira, Diana Neves
   dos Santos, Flavia Barreto
   Marques Hoekerberg, Yara Hahr
   Ribeiro Nogueira, Rita Maria
   Daumas, Regina Paiva
TI Accuracy of clinical criteria and an immunochromatographic strip test
   for dengue diagnosis in a DENV-4 epidemic
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Dengue; Accuracy; Sensitivity; Specificity; Diagnosis; Point-of-care
   systems; NS1
ID RIO-DE-JANEIRO; FEBRILE ILLNESSES; CASE DEFINITIONS; EMERGENCY-ROOM; NS1
   ANTIGEN; RAPID TEST; BRAZIL; CLASSIFICATION; SENSITIVITY; DISEASE
AB Background: Early diagnosis of dengue infection is important for decision-making and timely implementation of therapeutic measures. Although rapid NS1 assays have been used for dengue diagnosis since 2008, their performance in DENV-4 cases has not yet been fully assessed.
   Methods: We evaluated the accuracy of NS1 Bioeasy (TM) immunochromatographic strip test and of three clinical criteria for dengue diagnosis. Patients presenting at an emergency care center within 72 h of an acute febrile illness during the 2013 DENV-4 epidemic in Rio de Janeiro were consecutively enrolled for clinical and laboratory evaluation. We classified patients as suspected dengue or not according to three clinical criteria: WHO 2009, WHO 1997, and INI-FIOCRUZ. Dengue diagnosis was defined by RNA detection using RT-PCR and the negative cases were negative for all dengue serotypes and also Platelia (TM) NS1 ELISA. We obtained accuracy indices for NS1 Bioeasy (TM) alone and in combination with the clinical criteria.
   Results: RT-PCR for DENV-4 was positive in 148 out of 325 patients. Positive likelihood ratio, sensitivity, and specificity of NS1 Bioeasy (TM) with WHO 2009, WHO 1997, and INI-FIOCRUZ criteria were 22.6 (95 % CI 7.2-70.6), 40.6 % (95 % CI 32.3-49.3), and 98.2 % (95 % CI 94.9-99.6); 18.3 (95 % CI 6.8-49.2), 44.2 (95 % CI 35.8-52.9), 97.6 (95 % CI 94.0-99.3); 26.2 (95 % CI 6.5-106.5), 29.7 (95 % CI 22.4-37.8), 98.9 (95 % CI 96.0-99.9), respectively. WHO 1997 clinical criteria presented high sensitivity to rule out disease, but extremely low specificity. INI-FIOCRUZ had moderate sensitivity and specificity, and could target a group to a more specific test.
   Conclusions: Although the large rates of false negative results using NS1 Bioeasy (TM) rapid test advise against its use for triaging (rule out) purposes in DENV-4 epidemics, it could be used as a confirmatory tool in a bedside algorithm.
C1 [Buonora, Sibelle Nogueira; Lambert Passos, Sonia Regina; Quintela, Fernanda Moises; Rodrigues de Oliveira, Diana Neves; Marques Hoekerberg, Yara Hahr] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Lab Clin Epidemiol, Rio De Janeiro, Brazil.
   [do Carmo, Cleber Nascimento] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Rio De Janeiro, Brazil.
   [Daumas, Regina Paiva] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Germano Sinval Faria Teaching Primary Care Ctr, Rio De Janeiro, Brazil.
   [dos Santos, Flavia Barreto; Ribeiro Nogueira, Rita Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Flavivirus Lab, Rio De Janeiro, Brazil.
RP Buonora, SN (corresponding author), Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Lab Clin Epidemiol, Rio De Janeiro, Brazil.
EM sibellebuonora@gmail.com
RI DAUMAS, REGINA/M-9387-2013
OI DAUMAS, REGINA/0000-0002-8923-7711; Passos, Sonia/0000-0001-9947-2291;
   Buonora, Sibelle/0000-0002-0843-1783
CR Allonso D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113634
   [Anonymous], 2009, DENG DIAGN TREATM PR
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blacksell SD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/151967
   Bossuyt PM, 2003, AM J CLIN PATHOL, V119, P18, DOI 10.1309/8EXCCM6YR1THUBAF
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Diretoria Tecnica de Gestao, 2011, DENG DIAGN MAN CLIN
   Cecilia D, 2015, ARCH VIROL, V160, P323, DOI 10.1007/s00705-014-2217-x
   Chaterji S, 2011, AM J TROP MED HYG, V84, P224, DOI 10.4269/ajtmh.2011.10-0316
   Colombo TE, 2013, J CLIN VIROL, V58, P710, DOI 10.1016/j.jcv.2013.10.021
   Conroy AL, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-35
   da Costa VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094655
   Daumas RP, 2011, INFECTION, V39, P135, DOI 10.1007/s15010-011-0101-0
   Daumas RP, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-77
   DIETZ VJ, 1990, AM J EPIDEMIOL, V131, P693
   Domingo C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0877-0
   Failace RR, 2009, HEMOGRAMA MANUAL INT
   Sea VRF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064056
   Ferraz FO, 2013, J CLIN VIROL, V58, P41, DOI 10.1016/j.jcv.2013.06.015
   Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199
   Gan VC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060946
   Gregory CJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001400
   Gutierrez G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002385
   Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360
   Horstick O, 2014, AM J TROP MED HYG, V91, P621, DOI 10.4269/ajtmh.13-0676
   Huang SY, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0623-z
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   LAURITSEN JM, 2003, COMPREHENSIVE TOOL V
   Leo YS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-498
   Lima MRQ, 2014, CLIN INSIGHTS DENGUE, P27
   Low JGH, 2006, ANN ACAD MED SINGAP, V35, P783
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Macedo GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096314
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   NOGUEIRA RMR, 1990, MEM I OSWALDO CRUZ, V85, P253, DOI 10.1590/S0074-02761990000200022
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   Nujum ZT, 2014, PATHOG GLOB HEALTH, V108, P103, DOI 10.1179/2047773214Y.0000000131
   Pal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113411
   Paranavitane SA, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0570-8
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Lima MDQ, 2014, J VIROL METHODS, V204, P105, DOI 10.1016/j.jviromet.2014.02.031
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Setiati TE, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-22
   Silva FG, 2011, BEPA, V8, P14
   Tan LK, 2014, PLOS ONE, V9
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 46
TC 12
Z9 13
U1 0
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JAN 29
PY 2016
VL 16
AR 37
DI 10.1186/s12879-016-1368-7
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA DC0BC
UT WOS:000368880600001
PM 26822788
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Correa, LS
   Hokerberg, YHM
   Daumas, RP
   Brasil, P
AF Correa, Luana Sicuro
   Marques Hoekerberg, Yara Hahr
   Daumas, Regina Paiva
   Brasil, Patricia
TI Translation and cross-cultural adaptation of the World Health
   Organization staff questionnaire on dengue warning signs for use in
   Brazil
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Dengue; Questionnaires; Health Personnel
ID CLASSIFICATION; MULTICENTER; INSTRUMENTS; COUNTRIES; INFECTION;
   ATTITUDES; KNOWLEDGE
AB Early recognition of warning signs and treatment of severe dengue cases is the main strategy for reducing case-fatality, especially in children, who usually present few symptoms and can progress rapidly to dengue shock syndrome. The objective of this study was to elaborate the Brazilian version of the World Health Organization (WHO) staff questionnaire on the use and value of dengue warning signs, through translation and back-translation of the WHO questionnaire, followed by an expert panel consensus, pretest (n = 13), and pilot study (n = 20) of the preliminary version. Comparison of the original questionnaire in English and the back-translation showed that 8 of the 49 items had been extensively or completely altered, and three were rephrased. The expert panel added the warning signs listed by the Brazilian Ministry of Health. In the final version of the questionnaire, the item "ranking of warning signs" was rephrased and the answer option "do not know" was excluded. The Brazilian version of the WHO staff questionnaire allows assessing health professionals' experience and perceptions regarding the use of warning signs included in the recent dengue guidelines.
C1 [Correa, Luana Sicuro; Marques Hoekerberg, Yara Hahr; Brasil, Patricia] Fundacao Oswald Cruz, Inst Nacl Infectol Evandro Chagas, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Daumas, Regina Paiva] Fundacao Oswald Cruz, Escola Nacl Saude Publ Sergio Arouca, BR-21045900 Rio De Janeiro, RJ, Brazil.
RP Hokerberg, YHM (corresponding author), Fundacao Oswald Cruz, Inst Nacl Infectol Evandro Chagas, Ave Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM yarahahr@gmail.com
RI DAUMAS, REGINA/M-9387-2013
OI DAUMAS, REGINA/0000-0002-8923-7711
CR Alexander N, 2011, TROP MED INT HEALTH, V16, P936, DOI 10.1111/j.1365-3156.2011.02793.x
   Balasubramanian S, 2012, ARCH DIS CHILD, V97, P907, DOI 10.1136/archdischild-2012-301710
   Barniol J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-106
   Brasil, 2011, DENG DIAGN MAN CLIN
   Fundagao Nacional de Saude, 2002, DENG DIAGN MAN CLIN
   Herdman M, 1998, QUAL LIFE RES, V7, P323, DOI 10.1023/A:1024985930536
   Kularatne Sam, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1198
   Lee LK, 2011, ANN ACAD MED SINGAP, V40, P533
   Naing C, 2011, J COMMUN HEALTH, V36, P1044, DOI 10.1007/s10900-011-9407-1
   Reichenheim ME, 2007, REV SAUDE PUBL, V41, P665, DOI 10.1590/S0034-89102006005000035
   Santos Solange Laurentino dos, 2011, Ciênc. saúde coletiva, V16, P1319, DOI 10.1590/S1413-81232011000700066
   Shuaib F, 2010, W INDIAN MED J, V59, P139
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 13
TC 4
Z9 4
U1 0
U2 7
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD FEB
PY 2015
VL 31
IS 2
BP 247
EP 256
DI 10.1590/0102-311X00213913
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CF6IX
UT WOS:000352661500005
PM 25760159
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Hokerberg, YHM
   Reichenheim, ME
   Faerstein, E
   Passos, SRL
   Fritzell, J
   Toivanen, S
   Westerlund, H
AF Marques Hoekerberg, Yara Hahr
   Reichenheim, Michael Eduardo
   Faerstein, Eduardo
   Lambert Passos, Sonia Regina
   Fritzell, Johan
   Toivanen, Susanna
   Westerlund, Hugo
TI Cross-cultural validity of the demand-control questionnaire: Swedish and
   Brazilian workers
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Questionnaires; Working Conditions; Stress, Psychological;
   Cross-Cultural Comparison; Validation Studies; Factor analysis,
   Statistical
ID JOB CONTENT QUESTIONNAIRE; CONTROL-SUPPORT QUESTIONNAIRE; PSYCHOMETRIC
   PROPERTIES; CONSTRUCT-VALIDITY; SOCIAL SUPPORT; VERSION; RELIABILITY;
   STRESS; SCALES
AB OBJECTIVE: To evaluate the cross-cultural validity of the Demand-Control Questionnaire, comparing the original Swedish questionnaire with the Brazilian version.
   METHODS: We compared data from 362 Swedish and 399 Brazilian health workers. Confirmatory and exploratory factor analyses were performed to test structural validity, using the robust weighted least squares mean and variance-adjusted (WLSMV) estimator. Construct validity, using hypotheses testing, was evaluated through the inspection of the mean score distribution of the scale dimensions according to sociodemographic and social support at work variables.
   RESULTS: The confirmatory and exploratory factor analyses supported the instrument in three dimensions (for Swedish and Brazilians): psychological demands, skill discretion and decision authority. The best-fit model was achieved by including an error correlation between work fast and work intensely (psychological demands) and removing the item repetitive work (skill discretion). Hypotheses testing showed that workers with university degree had higher scores on skill discretion and decision authority and those with high levels of Social Support at Work had lower scores on psychological demands and higher scores on decision authority.
   CONCLUSIONS: The results supported the equivalent dimensional structures across the two culturally different work contexts. Skill discretion and decision authority formed two distinct dimensions and the item repetitive work should be removed.
C1 [Marques Hoekerberg, Yara Hahr; Lambert Passos, Sonia Regina] Fundacao Oswaldo Cruz, Lab Epidemiol Clin, Inst Nacl Infectol Evandro Chagas, BR-21040361 Rio De Janeiro, RJ, Brazil.
   [Reichenheim, Michael Eduardo; Faerstein, Eduardo] Univ Estado Rio de Janeiro, Dept Epidemiol, Inst Social Med, BR-20550011 Rio De Janeiro, RJ, Brazil.
   [Fritzell, Johan; Toivanen, Susanna] Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies, S-10691 Stockholm, Sweden.
   [Fritzell, Johan] Stockholm Univ, Karolinska Inst, Aging Res Center, S-10691 Stockholm, Sweden.
   [Westerlund, Hugo] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden.
RP Hokerberg, YHM (corresponding author), Fundacao Oswaldo Cruz, Lab Epidemiol Clin, Inst Nacl Infectol, Av Brasil,4036 Sala 201-A Manguinhos, BR-21040361 Rio De Janeiro, RJ, Brazil.
EM yarahahr@ipec.fiocruz.br
RI Westerlund, Hugo/A-3049-2012; Passos, Sonia/C-5292-2013
OI Westerlund, Hugo/0000-0002-8806-5698; Toivanen,
   Susanna/0000-0002-3965-1666; Fritzell, Johan/0000-0003-0496-3085;
   Passos, Sonia/0000-0001-9947-2291
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   CNPqNational Council for Scientific and Technological Development
   (CNPq); Swedish Foundation for International Cooperation in Research and
   Higher Education - STINT [drn IG2007-2 070]
FX The first author was supported by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico - CNPq and the Swedish
   Foundation for International Cooperation in Research and Higher
   Education - STINT (drn IG2007-2 070) during the sandwich doctoral period
   in Stockholm (January to April, 2009).
CR Alves MGD, 2004, REV SAUDE PUBL, V38, P164, DOI 10.1590/s0034-89102004000200003
   Backe EM, 2012, INT ARCH OCC ENV HEA, V85, P67, DOI 10.1007/s00420-011-0643-6
   Brown T.A., 2006, CONFIRMATORY FACTOR
   de Araujo TM, 2008, SCAND J WORK ENV HEA, P52
   Edimansyah B. A., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P412
   Escriba-Aguir V, 2001, Gac Sanit, V15, P142
   Finney SJ, 2006, QUANT METH EDUC BEHA, P269
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Fransson EI, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-62
   Griep RH, 2009, INT ARCH OCC ENV HEA, V82, P1163, DOI 10.1007/s00420-009-0460-3
   Hair J.F., 2006, MULTIVAR DATA ANAL, P770
   JOHNSON JV, 1988, AM J PUBLIC HEALTH, V78, P1336, DOI 10.2105/AJPH.78.10.1336
   Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322
   Karasek R, 2007, INT J BEHAV MED, V14, P189, DOI 10.1007/BF03002993
   Kawakami N, 1996, IND HEALTH, V34, P295, DOI 10.2486/indhealth.34.295
   Kline R. B, 2005, PRINCIPLES AND PRACT
   Landsbergis P, 2000, OCCUP MED, V15, P163
   Li J, 2004, IND HEALTH, V42, P260, DOI 10.2486/indhealth.42.260
   Hokerberg YHM, 2010, INT ARCH OCC ENV HEA, V83, P407, DOI 10.1007/s00420-009-0488-4
   Marsh HW, 2009, STRUCT EQU MODELING, V16, P439, DOI 10.1080/10705510903008220
   Mase J, 2012, IND HEALTH, V50, P467, DOI 10.2486/indhealth.MS1282
   Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8
   Muthen L. K., 1998, MPLUS STATISTICAL AN
   Niedhammer I, 2002, INT ARCH OCC ENV HEA, V75, P129, DOI 10.1007/s004200100270
   Sale JEM, 2002, INT ARCH OCC ENV HEA, V75, P145, DOI 10.1007/s004200100289
   Sanne B, 2005, SCAND J PUBLIC HEALT, V33, P166, DOI 10.1080/14034940410019217
   Schreurs PJG, 1998, WORK STRESS, V12, P66, DOI 10.1080/02678379808256849
   Smith CS, 1997, J ORGAN BEHAV, V18, P225, DOI 10.1002/(SICI)1099-1379(199705)18:3<225::AID-JOB797>3.0.CO;2-E
   Streiner D. L., 2008, HEALTH MEASUREMENT S
   Theorell T, 1990, HEALTHY WORK STRESS
   Theorell Tores, 1996, P69
   Toivanen S, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/873678
NR 32
TC 5
Z9 6
U1 0
U2 7
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD JUN
PY 2014
VL 48
IS 3
BP 486
EP 496
DI 10.1590/S0034-8910.2014048005126
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AP0TX
UT WOS:000341778900013
PM 25119944
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Reichenheim, ME
   Hokerberg, YHM
   Moraes, CL
AF Reichenheim, Michael E.
   Hoekerberg, Yara Hahr M.
   Moraes, Claudia Leite
TI Assessing construct structural validity of epidemiological measurement
   tools: a seven-step roadmap
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Epidemiologic Models; Validity of Tests; Methodology
ID ITEM RESPONSE THEORY; RELIABILITY; INSTRUMENTS; QUALITY
AB Guidelines have been proposed for assessing the quality of clinical trials, observational studies and validation studies of diagnostic tests. More recently, the COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) initiative extended those in regards to epidemiological measurement tools in general. Among various facets proposed for assessment is the validity of an instrument's dimensional structure (or structural validity). The purpose of this article is to extend these guidelines. A seven-step roadmap is proposed to examine (1) the hypothesized dimensional structure; (2) strength of component indicators regarding loading patterns and measurement errors; (3) measurement error correlations; (4) factor-based convergent and discriminant validity of scales; (5) item discrimination and intensity vis-a-vis the latent trait spectrum; and (6) the properties of raw scores; and (7) factorial invariance. The paper also holds that the suggested steps still require debate and are open to refinements.
C1 [Reichenheim, Michael E.; Moraes, Claudia Leite] Univ Estado Rio de Janeiro, Inst Med Social, BR-20559900 Rio De Janeiro, RJ, Brazil.
   [Hoekerberg, Yara Hahr M.] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil.
   [Moraes, Claudia Leite] Univ Estacio Sa, Programa Saude Familia, Rio De Janeiro, Brazil.
RP Reichenheim, ME (corresponding author), Univ Estado Rio de Janeiro, Inst Med Social, Dept Epidemiol, Rua Sao Francisco Xavier 524,7 Andar,Bloco D, BR-20559900 Rio De Janeiro, RJ, Brazil.
EM michael@ims.uerj.br
RI Moraes, claudia/AAK-9418-2020
OI Moraes, claudia/0000-0002-3223-1634
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [301221/2009-0, 302851/2008-9]; FaperjCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/110.756/2010]
FX M.E.R. was partially supported by the CNPq (process n. 301221/2009-0).
   C.L.M. was partially supported by the CNPq (process n. 302851/2008-9)
   and Faperj (process n. E-26/110.756/2010).
CR Aaronson N, 2002, QUAL LIFE RES, V11, P193
   Asparouhov T, STRUCT EQU IN PRESS
   Ayala R., 2009, THEORY PRACTICE ITEM
   Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010
   Brown T.A., 2006, CONFIRMATORY FACTOR
   Byrne B. M., 2012, STRUCTURAL EQUATION
   Cai L, 2010, PSYCHOMETRIKA, V75, P33, DOI 10.1007/s11336-009-9136-x
   Cohen J., 2003, APPL MULTIPLE REGRES
   De Boeck P, 2004, EXPLANATORY ITEM RES
   Embretson S. E., 2000, ITEM RESPONSE THEORY
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Geiser C, 2003, DATA ANAL MPLUS
   Gerbing DW, 1996, STRUCT EQU MODELING, V3, P62, DOI 10.1080/10705519609540030
   Gorsuch R. L., 1983, FACTOR ANAL
   Hair J.F., 2006, MULTIVAR DATA ANAL, P770
   Hancock G. R., 2010, REVIEWERS GUIDE QUAN
   Hardouin JB, 2007, STATA J, V7, P22, DOI 10.1177/1536867X0700700102
   Hardouin JB, 2011, STATA J, V11, P30, DOI 10.1177/1536867X1101100102
   Henson RK, 2001, MEAS EVAL COUNS DEV, V34, P177, DOI 10.1080/07481756.2002.12069034
   HOLZINGER K, 1939, STUDY FACTOR ANAL ST
   Joreskog K. G., 1993, TESTING STRUCTURAL E, P294
   Kankaras M, 2011, SOCIOL METHOD RES, V40, P279, DOI 10.1177/0049124111405301
   Kline R.B., 2011, PRINCIPLES PRACTICE
   Lohr KN, 1996, CLIN THER, V18, P979, DOI 10.1016/S0149-2918(96)80054-3
   Marsh HW, 2009, STRUCT EQU MODELING, V16, P439, DOI 10.1080/10705510903008220
   Marsh HW, 1996, J PERS SOC PSYCHOL, V70, P810, DOI 10.1037/0022-3514.70.4.810
   McDowell I, 1996, J Health Serv Res Policy, V1, P238
   Meade AW, 2004, ORGAN RES METHODS, V7, P361, DOI 10.1177/1094428104268027
   Milfont TL, 2010, INT J PSYCHOL RES, V3, P111
   Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8
   Molenaar IW, 2000, MSP5 WINDOWS USERS M
   Muthen B, 2002, MPLUS WEB NOTES 2002
   Muthen B, 2013, MPLUS WEB NOTE
   Muthen B, 2012, PSYCHOL METHODS, V17, P313, DOI 10.1037/a0026802
   Muthen LK, 1998, MPLUS USERS GUIDE
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879
   Rabe-Hesketh S, 2008, STAT METHODS MED RES, V17, P5, DOI 10.1177/0962280207081236
   Rasch G, 1960, PROBABLISTIC MODELS
   Raykov T, 2002, STRUCT EQU MODELING, V9, P195, DOI 10.1207/S15328007SEM0902_3
   Reichenheim ME, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-93
   REISE SP, 1993, PSYCHOL BULL, V114, P552, DOI 10.1037/0033-2909.114.3.552
   Reise SP, 2007, QUAL LIFE RES, V16, P19, DOI 10.1007/s11136-007-9183-7
   Samejima F., 1996, HDB MODERN ITEM RESP, P85, DOI DOI 10.1007/978-1-4757-2691-6_5
   Sijtsma K., 2002, INTRO NONPARAMETRIC
   Skrondal A., 2004, GEN LATENT VARIABLE
   Skrondal A, 2007, SCAND J STAT, V34, P712, DOI 10.1111/j.1467-9469.2007.00573.x
   Smith RM, 2002, J APPL MEAS, V4, P153
   Streiner DL, 2008, HLTH MEASUREMENT SCA
   Tabachnick BG, 2001, USING MULTIVARIATE S
   TAKANE Y, 1987, PSYCHOMETRIKA, V52, P393, DOI 10.1007/BF02294363
   van der Linden W. J., 1996, HDB MODERN ITEM RESP
   Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25
   Wilson M., 2005, CONSTRUCTING MEASURE
NR 53
TC 15
Z9 18
U1 0
U2 3
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD MAY
PY 2014
VL 30
IS 5
BP 927
EP 939
DI 10.1590/0102-311X00143613
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AJ7WZ
UT WOS:000337912800004
PM 24936810
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Guimaraes, PM
   Passos, SR
   Calvet, GA
   Hokerberg, YH
   Lessa, JL
   de Andrade, CA
AF Guimaraes, Patricia M.
   Passos, Sonia R.
   Calvet, Guilherme A.
   Hoekerberg, Yara H.
   Lessa, Jose L.
   de Andrade, Carlos A.
TI Suicide risk and alcohol and drug abuse in outpatients with HIV
   infection and Chagas disease
SO REVISTA BRASILEIRA DE PSIQUIATRIA
LA English
DT Article
DE Mental disorder; infectious disease; suicide; HIV; Chagas disease
ID COMMON MENTAL-DISORDERS; FAMILY HEALTH-PROGRAM; PSYCHIATRIC-DISORDERS;
   PREVALENCE; INDIVIDUALS; HIV/AIDS; ADULTS
AB Objective: To evaluate psychiatric comorbidities in outpatients receiving care for HIV and Chagas disease at Instituto de Pesquisa Clinica Evandro Chagas (IPEC), Fundacao Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.
   Methods: Cross-sectional study with a consecutive sample of 125 patients referred to an outpatient psychiatric clinic from February to December 2010. The Mini International Neuropsychiatric Interview (MINI) was used. Factors associated with more frequent mental disorders were estimated by odds ratios (OR) with 95% confidence intervals (95%Cl) by multiple logistic regression.
   Results: Seventy-six (60.8%) patients with HIV, 40 (32%) patients with Chagas disease, and nine (7.2%) patients with human T-Iymphotropic virus were interviewed. The majority were women (64%), with up to 8 years of formal education (56%), and unemployed (81.6%). The median age was 49 years. Suicide risk (n=71) (56%), agoraphobia (n=65) (52%), major depressive episode (n=56) (44.8%), and alcohol/drug abuse (n=43) (34.4%) predominated, the latter being directly associated with lower family income (OR = 2.64; 95%Cl 1.03-6.75) and HIV infection (OR = 5.24; 95%Cl 1.56-17.61). Suicide risk was associated with non-white skin color (OR = 2.21; 95%Cl 1.03-4.75), unemployment (OR = 2.72; 95%Cl 1.01-7.34), and diagnosis of major depression (OR = 3.34; 95%Cl 1.54-7.44).
   Conclusion: Measures targeting adverse socioeconomic conditions and psychiatric and psychological monitoring and care should be encouraged in this population, considering the association with abuse of alcohol/other psychoactive drugs and suicide risk.
C1 [Guimaraes, Patricia M.; Passos, Sonia R.; Hoekerberg, Yara H.; de Andrade, Carlos A.] Fundacao Oswaldo Cruz Fiocruz, Inst Pesquisa Clin Evandro Chagas IPEC, Lab Clin Epidemiol, Rio De Janeiro, Brazil.
   [Calvet, Guilherme A.] Fiocruz MS, IPEC, Lab HIV AIDS Clin Res, BR-21045900 Rio De Janeiro, Brazil.
   [Lessa, Jose L.] Univ Fed Rio de Janeiro, Inst Psychiat, Rio de Janeiro, Brazil.
RP Guimaraes, PM (corresponding author), Fiocruz MS, Lab Epidemiol Clin IPEC, Av Brasil,4036,Sala 201 A, BR-21045900 Rio De Janeiro, Brazil.
EM patricia.machado@ipec.fiocruz.br
RI Calvet, GA/G-6959-2013
OI Calvet, GA/0000-0002-3545-5238; Passos, Sonia/0000-0001-9947-2291
CR Amorim Patricia, 2000, Revista Brasileira de Psiquiatria, V22, P106
   [Anonymous], 1992, MMWR Recomm Rep, V41, P1
   [Anonymous], 1995, DSM 4 MAN DIAGN EST
   Badiee J, 2012, J AFFECT DISORDERS, V136, P993, DOI 10.1016/j.jad.2011.06.044
   Bertolote JM, 2003, BRIT J PSYCHIAT, V183, P382, DOI 10.1192/bjp.183.5.382
   Bertolote JM, 2010, REV BRAS PSIQUIATR, V32, pS87, DOI 10.1590/S1516-44462010000600005
   Bing EG, 2001, ARCH GEN PSYCHIAT, V58, P721, DOI 10.1001/archpsyc.58.8.721
   Botega N., 2006, PRATICA PSIQUIATRICA
   Botega NJ, 2010, GEN HOSP PSYCHIAT, V32, P396, DOI 10.1016/j.genhosppsych.2010.02.004
   Brasil. Ministerio da Previdencia Social, 2010, EST PREV SOC
   Brasil. Ministerio da Sande Secretaria de Vigilancia em Saude Coordenagao Nacional de DST e AIDS, REC TER ANTRR AD AD
   Brasil. Ministerio da Saude Secretaria de Vigilancia em Saude, 2003, MIN SAUD SER MAN, V3
   Chander G, 2006, DRUGS, V66, P769, DOI 10.2165/00003495-200666060-00004
   Chikezie UE, 2012, AIDS CARE, V24, P843, DOI 10.1080/09540121.2011.645008
   Ciesla JA, 2001, AM J PSYCHIAT, V158, P725, DOI 10.1176/appi.ajp.158.5.725
   Cooperman NA, 2005, J BEHAV MED, V28, P149, DOI 10.1007/s10865-005-3664-3
   Costa Albanita Gomes da, 2005, Cad Saude Publica, V21, P73, DOI 10.1590/S0102-311X2005000100009
   Coelho FMD, 2009, CAD SAUDE PUBLICA, V25, P59, DOI 10.1590/S0102-311X2009000100006
   Ferrando SJ, 2008, CRIT CARE CLIN, V24, P889, DOI 10.1016/j.ccc.2008.05.007
   Fiellin David A, 2004, Top HIV Med, V12, P77
   Fortes S, 2008, REV BRAS PSIQUIATR, V30, P32, DOI 10.1590/S1516-44462006005000066
   Goncalves DM, 2008, CAD SAUDE PUBLICA, V24, P2043, DOI 10.1590/S0102-311X2008000900010
   Himelhoch S, 2009, AIDS, V23, P1735, DOI 10.1097/QAD.0b013e32832b428f
   Hosmer DW, 2000, APPL LOGISTIC REGRES
   de Carvalho AGJ, 2009, BRAZ J INFECT DIS, V13, P5, DOI 10.1590/S1413-86702009000100003
   Komiti A, 2001, AUST NZ J PSYCHIAT, V35, P747, DOI 10.1046/j.1440-1614.2001.00943.x
   Maccaferri G E, 2012, Rev Med Suisse, V8, P362
   Ministerio da Saude. Secretaria de Vigilancia em Saude, 2005, Rev Soc Bras Med Trop, V38 Suppl 3, P7
   Myer L, 2008, AIDS PATIENT CARE ST, V22, P147, DOI 10.1089/apc.2007.0102
   Ozaki Y, 2011, QUAL LIFE RES, V20, P133, DOI 10.1007/s11136-010-9726-1
   Reichenheim ME, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-66
   Rocha Saulo Vasconcelos, 2010, Rev. bras. epidemiol., V13, P630, DOI 10.1590/S1415-790X2010000400008
   Santos Élem Guimarães dos, 2010, J. bras. psiquiatr., V59, P238, DOI 10.1590/S0047-20852010000300011
   Sewell MC, 2000, PSYCHOSOMATICS, V41, P294, DOI 10.1176/appi.psy.41.4.294
   Silveira Marysabel Pinto Telis, 2002, Braz J Infect Dis, V6, P164, DOI 10.1590/S1413-86702002000400003
   Stumpf BP, 2008, INT J PSYCHIAT MED, V38, P345, DOI 10.2190/PM.38.3.i
   Wackemann PV, 2008, J NEUROL SCI, V269, P152, DOI 10.1016/j.jns.2008.01.006
   World Health Organization, 2013, SUIC PREV SUPRE
NR 38
TC 8
Z9 8
U1 0
U2 8
PU ASSOC BRASILEIRA PSIQUIATRIA
PI SAO PAULO
PA SUBSCRIPTION DEPARTMENT, RUA PEDRO DE TOLEDO, 967 - CASA 01, SAO PAULO,
   SP 04039-032  A, BRAZIL
SN 1516-4446
EI 1809-452X
J9 REV BRAS PSIQUIATR
JI Rev. Bras. Psiquiatr.
PD APR-JUN
PY 2014
VL 36
IS 2
BP 131
EP 137
DI 10.1590/1516-4446-2013-1219
PG 7
WC Psychiatry
SC Psychiatry
GA AI8ZJ
UT WOS:000337215200006
PM 24845116
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Castro, MMLD
   Hokerberg, YHM
   Passos, SRL
AF Lobo Dinis Castro, Marcelle Maria
   Marques Hoekerberg, Yara Hahr
   Lambert Passos, Sonia Regina
TI Dimensional validity of WHOQOL-BREF in health workers
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Validation Studies; Health Personnel; Quality of Life; Working
   Environment
ID QUALITY-OF-LIFE; PSYCHOMETRIC PROPERTIES; OLDER-ADULTS;
   GENERAL-POPULATION; SHORT VERSION; ORGANIZATION; INSTRUMENT;
   OUTPATIENTS; DEPRESSION; RELIABILITY
AB This study's objective was to revisit the internal consistency and convergent and discriminant factorial validity of the Brazilian version of WHOQOL-BREF, in a cross-sectional study of 386 health workers. Confirmatory factor analysis was used to test WHOQOL-BREF's structure (24 and 26 items) and the model suggested by exploratory factor analysis. Internal consistency was measured through composite reliability; convergent and discriminant validity by average variance extracted and factor correlations. The best-fit model, suggested by exploratory factor analysis (26 items), had 6 factors: 4 theoretically proposed (general, psychological, social relationships, and environment) and 2 obtained by subdividing the physical domain. Items "energy" and "security" (from physical and environment domains) were relocated to the psychological domain. Composite reliability was good (> 0.70), except for the general factor. Convergent and discriminant validity were adequate for social relationships and physical 2. Controversies on WHOQOL-BREF's dimensionality persist, particularly in the physical domain.
C1 [Lobo Dinis Castro, Marcelle Maria; Marques Hoekerberg, Yara Hahr; Lambert Passos, Sonia Regina] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Lobo Dinis Castro, Marcelle Maria] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, BR-21040900 Rio De Janeiro, RJ, Brazil.
RP Castro, MMLD (corresponding author), Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM lobodinis@gmail.com
RI Passos, Sonia/C-5292-2013
OI Passos, Sonia/0000-0001-9947-2291
CR [Anonymous], 1998, PSYCHOL MED, V28, P551
   Berlim MT, 2007, PSYCHIAT RES, V153, P253, DOI 10.1016/j.psychres.2006.07.006
   Berlim MT, 2003, PSYCHIAT SERV, V54, P254, DOI 10.1176/appi.ps.54.2.254
   Blay SL, 2011, CAD SAUDE PUBLICA, V27, P677, DOI 10.1590/S0102-311X2011000400007
   Brasil Ministerio do Trabalho e do Emprego, 2002, CLASS BRAS OC CBO 20
   Brown T.A., 2006, CONFIRMATORY FACTOR
   Calumbi RA, 2010, REV BRAS ANESTESIOL, V60, P42, DOI 10.1590/S0034-70942010000100005
   Chachamovich E, 2008, GERONTOLOGIST, V48, P593, DOI 10.1093/geront/48.5.593
   Chacharnovich E, 2009, J CLIN EPIDEMIOL, V62, P37, DOI 10.1016/j.jclinepi.2008.03.002
   Chen KH, 2006, SOC INDIC RES, V79, P215, DOI 10.1007/s11205-005-0211-0
   Chung WS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-630
   DIVISION OF MENTAL HEALTH AND PREVENTION OF SUBSTANCE ABUSE WORLD HEALTH ORGANIZATION, 1998, PROGR MENT HLTH WHOQ
   Fang CT, 2002, QUAL LIFE RES, V11, P753, DOI 10.1023/A:1020870402019
   Fleck MPA, 2000, REV SAUDE PUBL, V34, P178, DOI 10.1590/S0034-89102000000200012
   Gazalle FK, 2005, J AFFECT DISORDERS, V86, P313, DOI 10.1016/j.jad.2005.01.003
   Hair JF, 2009, SEM CONFIRMATORY FAC
   Jaracz K, 2006, SCAND J CARING SCI, V20, P251, DOI 10.1111/j.1471-6712.2006.00401.x
   Kalfoss MH, 2008, EUR J AGEING, V5, P77, DOI 10.1007/s10433-008-0070-z
   KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k
   Li KG, 2009, SOC INDIC RES, V90, P489, DOI 10.1007/s11205-008-9272-1
   Min SK, 2002, QUAL LIFE RES, V11, P593, DOI 10.1023/A:1016351406336
   Moreno Arlinda B., 2006, Cad. Saúde Pública, V22, P2585, DOI 10.1590/S0102-311X2006001200009
   Muthen B. O., 1998, MPLUS TECHNICAL APPE
   Ohaeri JU, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-37
   Ohaeri JU, 2009, ANN SAUDI MED, V29, P98, DOI 10.4103/0256-4947.51790
   Paschoa Simone, 2007, Acta paul. enferm., V20, P305, DOI 10.1590/S0103-21002007000300010
   Paskulin L, 2009, INT NURS REV, V56, P109, DOI 10.1111/j.1466-7657.2008.00671.x
   Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4
   Rabin EG, 2008, EUR J ONCOL NURS, V12, P53, DOI 10.1016/j.ejon.2007.06.003
   Reichenheim ME, 2007, REV SAUDE PUBL, V41, P665, DOI 10.1590/S0034-89102006005000035
   Romao APMS, 2009, INT J CLIN PRACT, V63, P707, DOI 10.1111/j.1742-1241.2009.02034.x
   Skevington SM, 2002, QUAL LIFE RES, V11, P135, DOI 10.1023/A:1015013312456
   Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00
   Taylor WJ, 2004, ARTHRIT RHEUM-ARTHR, V51, P350, DOI 10.1002/art.20398
   Trompenaars F, 2005, QUAL LIFE RES, V14, P151, DOI 10.1007/s11136-004-0787-x
   Usefy AR, 2010, COMMUNITY MENT HLT J, V46, P139, DOI 10.1007/s10597-009-9282-8
   von Steinbuchel Nicole, 2006, Eur J Ageing, V3, P116, DOI 10.1007/s10433-006-0024-2
   What quality of life? The WHOQOL Group, 1996, WORLD HLTH FORUM, V17, P354
   Xia P, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-37
NR 39
TC 9
Z9 10
U1 0
U2 12
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD JUL
PY 2013
VL 29
IS 7
BP 1357
EP 1369
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 180VN
UT WOS:000321627000010
PM 23843003
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Orofino, DHG
   Passos, SRL
   de Andrade, CAF
   Nigri, D
   Werneck, LD
   de Oliveira, RC
   Hokerberg, YHM
AF Goncalves Orofino, Dulce Helena
   Lambert Passos, Sonia Regina
   Ferreira de Andrade, Carlos Augusto
   Nigri, Daniel
   Werneck, Lucia dos Santos
   de Oliveira, Raquel Carvalhaes
   Marques Hoekerberg, Yara Hahr
TI ACCURACY AND INTEROBSERVER VARIATION OF THREE CLINICAL DECISION RULES
   FOR THE DIAGNOSIS OF STREPTOCOCCAL PHARYNGITIS
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Article
DE validation study; sensitivity; specificity; test reproducibility;
   streptococcal pharyngitis; rheumatic fever
ID MANAGEMENT; CHILDREN
AB We evaluated the accuracy and interobserver variation of 3 clinical decision rules for streptoccocal pharyngitis diagnosis. Oropharyngeal swab culture was the reference. The Abu Reesh rule had the highest sensitivity and the World Health Organization rule showed the highest specificity. The interobserver variation of those rules indicates the need for better training of clinicians.
C1 [Goncalves Orofino, Dulce Helena; Lambert Passos, Sonia Regina; Ferreira de Andrade, Carlos Augusto; de Oliveira, Raquel Carvalhaes; Marques Hoekerberg, Yara Hahr] Fundacao Oswaldo Cruz, Lab Clin Epidemiol, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil.
   [Goncalves Orofino, Dulce Helena; Nigri, Daniel] Souza Marques Med Sch, Rio De Janeiro, Brazil.
   [Werneck, Lucia dos Santos] Prontobaby Hosp, Rio De Janeiro, Brazil.
RP Orofino, DHG (corresponding author), Fundacao Oswaldo Cruz, Lab Clin Epidemiol, Inst Pesquisa Clin Evandro Chagas, Ave Brasil 4036 Sala 301-A Manguinhos, Rio De Janeiro, Brazil.
EM dulceorofino@yahoo.com.br
RI Passos, Sonia/C-5292-2013; Oliveira, Raquel de V C de/S-7443-2016
OI Passos, Sonia/0000-0001-9947-2291; Oliveira, Raquel de V C
   de/0000-0001-9387-8645
FU Technological Research and Development Program of the IPEC/FIOCRUZ;
   Carlos Chagas Foundation of Research Support-FAPERJ [JCNE
   E-26/101-511/2010]; Carlos Chagas Foundation of Research Support-FAPERJ
   (PIBIC CNPq scholarship)
FX This study was funded by the Technological Research and Development
   Program (PIPDT-2011) of the IPEC/FIOCRUZ and the Carlos Chagas
   Foundation of Research Support-FAPERJ (S. R. L. P. had a fellowship JCNE
   E-26/101-511/2010, and D.N. had a PIBIC CNPq scholarship.). The funding
   sources had no role in the following: study design and conduct; and data
   collection, analysis and interpretation. D.H.G.O. had full access to all
   data and final responsibility for the decision to submit for publication
   on behalf of all authors. The authors have no other funding or conflicts
   of interest to disclose.
CR Donner-Banzhoff N, 2002, FAM PRACT, V19, P466, DOI 10.1093/fampra/19.5.466
   Joachim L, 2010, PEDIATRICS, V126, pE608, DOI 10.1542/peds.2010-0569
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Rimoin AW, 2005, ARCH DIS CHILD, V90, P1066, DOI 10.1136/adc.2004.069120
   Shaikh N, 2012, J PEDIATR-US, V160, P487, DOI 10.1016/j.jpeds.2011.09.011
   Shaikh N, 2010, PEDIATRICS, V126, pE557, DOI 10.1542/peds.2009-2648
   Steinhoff MC, 2005, ACTA PAEDIATR, V94, P1038, DOI 10.1080/08035250510027994
   Steinhoff MC, 1997, LANCET, V350, P918, DOI 10.1016/S0140-6736(97)03317-5
   Walker CLF, 2006, J PEDIATR-US, V149, P64, DOI 10.1016/j.jpeds.2006.03.005
   World Health Organization, 1995, MAN AC RESP INF CHIL
NR 10
TC 3
Z9 3
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD JUN
PY 2013
VL 32
IS 6
BP 686
EP 687
DI 10.1097/INF.0b013e3182868b32
PG 2
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA 147ZR
UT WOS:000319211700026
PM 23340556
DA 2020-11-24
ER

PT J
AU Luz, TCB
   Luiza, VL
   Avelar, FG
   Hokerberg, YHM
   Passos, SRL
AF Borges Luz, Tatiana Chama
   Luiza, Vera Lucia
   Avelar, Fernando Genovez
   Marques Hoekerberg, Yara Hahr
   Lambert Passos, Sonia Regina
TI Use of medication among hospital workers
SO CIENCIA & SAUDE COLETIVA
LA Portuguese
DT Article
DE Use of medication; Associated factors; Workers
ID SELF-RATED HEALTH; DRUG-USE; GENERAL-POPULATION; ADULT-POPULATION;
   MENTAL-HEALTH; ASSOCIATION; STRESS; BRAZIL; MORBIDITY; SERVICES
AB Although medication is acknowledged as a key element in treating health problems, there is little information available on the use of medication by hospital workers. To estimate the prevalence and describe the patterns of medication consumption by hospital workers and to identify the factors associated with such consumption in this population, data from the "PROSEC" baseline cohort were analyzed (n=417). The prevalence of overall medication consumption was 72.4%, most of which was for nervous complaints (25.4%), especially analgesics (17.8%). Use of any amount of medication was independently associated with gender, number of medically diagnosed conditions and health problem in the two weeks prior to the interview. Use of a drug was significantly associated with income whereas self-diagnosed health problems were independently related with the use of two or more pharmaceutical products. The high prevalence of medication usage in this population, with analgesics being the most consumed medication, should be seen as a cause for concern, since many consumers are unaware that these products are not exempt from risk. Women and individuals in poor health are the main candidates for intervention programs in order to promote adequate and proper use of these pharmaceutical products.
C1 [Borges Luz, Tatiana Chama] Fundacao Oswaldo Cruz LEAM CpqRR Fiocruz, Ctr Pesquisa Rene Rachou, Lab Epidemiol & Antropol Med, BR-30190002 Belo Horizonte, MG, Brazil.
   [Luiza, Vera Lucia; Avelar, Fernando Genovez] Fundacao Oswaldo Cruz NAF ENSP Fiocruz, Escola Nacl Saude Publ Sergio Arouca, Nucleo Assistencia Farmaceut, Rio De Janeiro, Brazil.
   [Marques Hoekerberg, Yara Hahr; Lambert Passos, Sonia Regina] Fundacao Oswaldo Cruz IPEC Fiocruz, Inst Pesquisa Clin Evandro Chagas, Lab Epidemiol Clin, Rio De Janeiro, Brazil.
RP Luz, TCB (corresponding author), Fundacao Oswaldo Cruz LEAM CpqRR Fiocruz, Ctr Pesquisa Rene Rachou, Lab Epidemiol & Antropol Med, Av Augusto de Lima 1715-609, BR-30190002 Belo Horizonte, MG, Brazil.
EM tatianachama@cpqrr.fiocruz.br
RI Luiza, Vera Lucia/F-6070-2012; Passos, Sonia/C-5292-2013
OI Luiza, Vera Lucia/0000-0001-6245-7522; Passos, Sonia/0000-0001-9947-2291
CR Acurcio Francisco de Assis, 2006, Cad. Saúde Pública, V22, P87, DOI 10.1590/S0102-311X2006000100010
   Agencia Nacional de Vigilancia Sanitaria (ANVISA), BANC DAD MED AG NAC
   [Anonymous], 2007, CAD SAUDE PUBLICA, V23, P1423, DOI 10.1590/S0102-311X2007000600017
   [Anonymous], 2004, DEF 2004 2005
   Aquino Daniela Silva de, 2008, Ciênc. saúde coletiva, V13, P733
   Arrais Paulo Sérgio Dourado, 2005, Cad. Saúde Pública, V21, P1737, DOI 10.1590/S0102-311X2005000600021
   Boeuf-Cazou O, 2009, PHARMACOEPIDEM DR S, V18, P335, DOI 10.1002/pds.1713
   Brasil. Ministerio do Trabalho e Emprego (MTE), CLASS BRAS OC CBO 20
   Barros JAC, 2008, CIENC SAUDE COLETIVA, V13, P579, DOI 10.1590/S1413-81232008000700007
   Carrasco-Garrido P, 2008, PHARMACOEPIDEM DR S, V17, P193, DOI 10.1002/pds.1455
   Carvalho Marcelo Felga de, 2005, Cad. Saúde Pública, V21, pS100, DOI 10.1590/S0102-311X2005000700011
   Cheng Y, 2005, SOC SCI MED, V61, P41, DOI 10.1016/j.socscimed.2004.11.039
   De Lucia R, 1988, REV BRAS SAUDE OCUP, V16, P51
   DeLucia R, 1987, AMB Rev Assoc Med Bras, V33, P215
   Dewa CS, 2005, INT J LAW PSYCHIAT, V28, P496, DOI 10.1016/j.ijlp.2005.08.003
   ESTRYNBEHAR M, 1990, BRIT J IND MED, V47, P20
   Furu K, 1997, J CLIN EPIDEMIOL, V50, P341, DOI 10.1016/S0895-4356(96)00362-9
   GRUPEMEF-Grupo dos Profissionais Executivos do Mercado Farmaceutico, VEND NOM R US 1000 U
   Guerra AA, 2004, REV PANAM SALUD PUBL, V15, P168, DOI 10.1590/S1020-49892004000300005
   Holmgren K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-73
   Jinks Annette M, 2003, J Nurs Manag, V11, P343, DOI 10.1046/j.1365-2834.2003.00387.x
   Katsarava Zaza, 2001, Drug Safety, V24, P921, DOI 10.2165/00002018-200124120-00005
   Kawano Y, 2008, J OCCUP HEALTH, V50, P79, DOI 10.1539/joh.50.79
   Kongkaew C, 2008, ANN PHARMACOTHER, V42, P1017, DOI 10.1345/aph.1L037
   LAUKKANEN P, 1992, AGE AGEING, V21, P343, DOI 10.1093/ageing/21.5.343
   LEFEVRE F, 1983, REV SAUDE PUBL, V17, P500, DOI 10.1590/S0034-89101983000600007
   Leite SN, 2008, CIENC SAUDE COLETIVA, V13, P793, DOI 10.1590/S1413-81232008000700029
   Lima J, 2009, REV ESC ENFERM USP, V43, P670, DOI 10.1590/S0080-62342009000300024
   Long J. S., 2003, REGRESSION MODELS CA
   Loyola Filho Antônio I. de, 2005, Cad. Saúde Pública, V21, P545, DOI 10.1590/S0102-311X2005000200021
   Loyola Filho Antônio I. de, 2006, Cad. Saúde Pública, V22, P2657, DOI 10.1590/S0102-311X2006001200015
   Lundberg L, 1998, HEALTH POLICY, V44, P123, DOI 10.1016/S0168-8510(98)00009-8
   Luz Tatiana Chama Borges, 2006, Rev. bras. epidemiol., V9, P514, DOI 10.1590/S1415-790X2006000400012
   Miilunpalo S, 1997, J CLIN EPIDEMIOL, V50, P517, DOI 10.1016/S0895-4356(97)00045-0
   Moller L, 1996, J EPIDEMIOL COMMUN H, V50, P423, DOI 10.1136/jech.50.4.423
   Organizacao Pan-Americana da Saude (Opas), 2005, AV ASS FARM BRAS EST
   OSORIODECASTRO CG, 2000, ESTUDOS UTILIZACAO M
   Pelfrene E, 2004, SOC SCI MED, V59, P433, DOI 10.1016/j.socscimed.2003.11.002
   PERNEGER TV, 1994, NEW ENGL J MED, V331, P1675, DOI 10.1056/NEJM199412223312502
   Piko BF, 2006, INT J NURS STUD, V43, P311, DOI 10.1016/j.ijnurstu.2005.05.003
   Rothman KJ, 2008, MODERN EPIDEMIOLOGY
   ROZEMBERG B, 1994, REV SAUDE PUBL, V28, P300, DOI 10.1590/S0034-89101994000400010
   Sans S., 2002, Gac Sanit, V16, P121
   Sihvo S, 2000, EUR J CLIN PHARMACOL, V56, P495, DOI 10.1007/s002280000145
   Silveira Fernando Gaiger, 2002, Ciênc. saúde coletiva, V7, P719, DOI 10.1590/S1413-81232002000400009
   Sinokki M, 2009, J AFFECT DISORDERS, V115, P36, DOI 10.1016/j.jad.2008.07.009
   Stansfeld SA, 1999, OCCUP ENVIRON MED, V56, P302, DOI 10.1136/oem.56.5.302
   Theme MM, 2008, REV SAUDE PUBL, V42, P73, DOI 10.1590/S0034-89102008000100010
   Tolman KG, 1998, AM J MED, V105, P13, DOI DOI 10.1016/S0002-9343(98)00070-9
   Tomasi Elaine, 2007, Rev. bras. epidemiol., V10, P66
   VFA- Bio-Association of Research-Based Pharma-ceutical Companies, PHARM MARK
   WHO Collaborating Centre for Drug Statistics Methodology, AN THER CHEM ATC CLA
   Wolff T, 2009, ANN INTERN MED, V150, P405, DOI 10.7326/0003-4819-150-6-200903170-00009
   World Health Organization, 2004, INV US MED CONS
   World Health Organization, 2003, INTR DRUG UT RES
NR 55
TC 0
Z9 1
U1 0
U2 3
PU ABRASCO
PI RIO DE JANEIRO
PA RUA HESPERIA, 16-PARTE MANGUINHOS, RIO DE JANEIRO, 21050-040, BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD FEB
PY 2012
VL 17
IS 2
BP 499
EP 509
DI 10.1590/S1413-81232012000200023
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 880CX
UT WOS:000299383400024
PM 22267044
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Guimaraes, PMQ
   de Andrade, CAF
   Calvet, GA
   Hokerberg, YHM
   Castro, MMLD
   Lessa, JLM
   Passos, SRL
AF Quintaes Guimaraes, Patricia Machado
   Ferreira de Andrade, Carlos Augusto
   Calvet, Guilherme Amaral
   Marques Hoekerberg, Yara Hahr
   Lobo Dinis Castro, Marcelle Maria
   Martins Lessa, Jose Luiz
   Lambert Passos, Sonia Regina
TI Profile of psychiatric comorbidity in patients in diagnosis of HIV, HTLV
   and Chagas' disease followed up in ambulatory psychiatric hospital of
   reference in infectious diseases
SO REVISTA BRASILEIRA DE PSIQUIATRIA
LA Portuguese
DT Meeting Abstract
C1 [Quintaes Guimaraes, Patricia Machado; Ferreira de Andrade, Carlos Augusto; Calvet, Guilherme Amaral; Marques Hoekerberg, Yara Hahr; Lobo Dinis Castro, Marcelle Maria; Martins Lessa, Jose Luiz; Lambert Passos, Sonia Regina] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas IPEC, BR-21045900 Rio De Janeiro, RJ, Brazil.
RI Calvet, GA/G-6959-2013; Passos, Sonia/C-5292-2013
OI Calvet, GA/0000-0002-3545-5238; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ASSOC BRASILEIRA PSIQUIATRIA
PI SAO PAULO
PA SUBSCRIPTION DEPARTMENT, RUA PEDRO DE TOLEDO, 967 - CASA 01, SAO PAULO,
   SP 04039-032  A, BRAZIL
SN 1516-4446
J9 REV BRAS PSIQUIATR
JI Rev. Bras. Psiquiatr.
PD NOV
PY 2011
VL 33
SI SI
BP S21
EP S21
PG 1
WC Psychiatry
SC Psychiatry
GA 884QM
UT WOS:000299722600037
OA DOAJ Gold
DA 2020-11-24
ER

PT J
AU Hokerberg, YHM
   Faerstein, E
   de Andrade, CAF
   Fernandes, R
   Passos, RL
AF Hoekerberg, Y. H. M.
   Faerstein, E.
   de Andrade, C. A. F.
   Fernandes, R.
   Passos, R. L.
TI DEMAND AND CONTROL AT WORK AND BLOOD PRESSURE: SYSTEMATIC REVIEW AND
   META-ANALYSIS
SO JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
LA English
DT Meeting Abstract
C1 [Hoekerberg, Y. H. M.; de Andrade, C. A. F.; Fernandes, R.; Passos, R. L.] Fundacao Oswaldo Cruz, Evandro Chagas Clin Res Inst, Rio De Janeiro, Brazil.
   [Faerstein, E.] Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0143-005X
J9 J EPIDEMIOL COMMUN H
JI J. Epidemiol. Community Health
PD AUG
PY 2011
VL 65
SU 1
BP A252
EP A252
DI 10.1136/jech.2011.142976i.50
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 807MG
UT WOS:000293901801214
OA Bronze
DA 2020-11-24
ER

PT J
AU Vitorino, RL
   Grinsztejn, BG
   de Andrade, CAF
   Hokerberg, YHM
   de Souza, CTV
   Friedman, RK
   Passos, SRL
AF Vitorino, Raquel Loja
   Grinsztejn, Beatriz Gilda
   Ferreira de Andrade, Carlos Augusto
   Marques Hoekerberg, Yara Hahr
   Vieira de Souza, Claudia Teresa
   Friedman, Ruth Khalili
   Lambert Passos, Sonia Regina
TI Systematic review of the effectiveness and safety of assisted
   reproduction techniques in couples serodiscordant for human
   immunodeficiency virus where the man is positive
SO FERTILITY AND STERILITY
LA English
DT Article
DE Artificial insemination; assisted reproduction; HIV infection;
   infertility; intracytoplasmic sperm injection (ICSI); in vitro
   fertilization; reproductive techniques; systematic review
ID INTRACYTOPLASMIC SPERM INJECTION; IN-VITRO FERTILIZATION; INFECTED MALE
   PARTNER; INTRAUTERINE INSEMINATION; HEPATITIS-C; HIV; ICSI; CYCLES;
   WOMEN; METAANALYSIS
AB Objective: To evaluate the effectiveness and safety of assisted reproduction techniques (ART) in human immunodeficiency virus (HIV) serodiscordant couples.
   Design: Systematic review of five databases of noncomparative open intervention and observational studies of serodiscordant couples undergoing ART, with study selection and data extraction performed independently and in duplicate.
   Setting: Tertiary fertility centers.
   Patient(s): HIV serodiscordant couples where the man is HIV positive.
   Intervention(s): Intrauterine insemination (IUI), in vitro fertilization (IVF), or intracytoplasmic injection (ICSI) performed after washed semen viral testing.
   Main Outcome Measure(s): Pregnancy rates per cycle, cumulative pregnancy, abortion rate, and HIV seroconversion in newborns or women.
   Result(s): Of the 658 abstracts retrieved, 41 were selected for review, and 17 full articles were included (3,900 IUI cycles in 1,184 couples in 11 aggregated studies and 738 ICSI/IVF cycles in 579 couples across 10 studies). The IUI and ICSI results were, respectively: pregnancy rates per cycle, 18% and 38.1%; cumulative pregnancy, 50% and 52.9%; and abortion rate, 15.6% and 20.6%. No seroconversions in women or newborns were detectable at birth or after 3 to 6 months.
   Conclusion(s): Cumulative evidence suggests that ART is safe and effective for avoiding horizontal and vertical transmission in HIV serodiscordant couples. (Fertil Steril (R) 2011;95:1684-90. (C)2011 by American Society for Reproductive Medicine.)
C1 [Vitorino, Raquel Loja; Ferreira de Andrade, Carlos Augusto; Marques Hoekerberg, Yara Hahr; Vieira de Souza, Claudia Teresa; Lambert Passos, Sonia Regina] Fundacao Oswaldo Cruz, Lab Clin Epidemiol, BR-21045900 Rio De Janeiro, Brazil.
   [Grinsztejn, Beatriz Gilda; Friedman, Ruth Khalili] Fundacao Oswaldo Cruz, Evandro Chagas Clin Res Inst IPEC, STD AIDS Clin Res Lab, BR-21045900 Rio De Janeiro, Brazil.
RP Passos, SRL (corresponding author), Fundacao Oswaldo Cruz, Lab Clin Epidemiol, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM sonialambert@ipec.fiocruz.br
RI Passos, Sonia/C-5292-2013
OI Passos, Sonia/0000-0001-9947-2291
FU Oswaldo Cruz Foundation (Fiocruz)
FX Scholarship funding from the Oswaldo Cruz Foundation (Fiocruz) (to
   R.L.V.).
CR Andersen AN, 2009, HUM REPROD, V24, P1267, DOI 10.1093/humrep/dep035
   Barreiro P, 2007, HUM REPROD, V22, P2353, DOI 10.1093/humrep/dem226
   Bujan L, 2004, FERTIL STERIL, V82, P857, DOI 10.1016/j.fertnstert.2004.02.128
   Louis B, 2007, EUR J OBSTET GYN R B, V135, P76, DOI 10.1016/j.ejogrb.2007.04.011
   Chu MC, 2005, REPROD BIOMED ONLINE, V10, P130, DOI 10.1016/S1472-6483(10)60814-0
   Chu Micheline C., 2006, Archives of Gynecology and Obstetrics, V274, P155, DOI 10.1007/s00404-006-0164-9
   Dovey S, 2008, FERTIL STERIL, V90, P2281, DOI 10.1016/j.fertnstert.2007.10.057
   Egger M, 1998, BRIT MED J, V316, P140
   Egger M., 2008, SYSTEMATIC REV HLTH, P211, DOI [10.1002/9780470693926.ch12, DOI 10.1002/9780470693926.CH12]
   *ETH COMM AM SOC R, 2004, FERTIL STERIL S1, V82
   Farhi J, 2007, FERTIL STERIL, V88, P396, DOI 10.1016/j.fertnstert.2006.11.187
   Garrido N, 2004, HUM REPROD, V19, P2581, DOI 10.1093/humrep/deh460
   Kovacic B, 2010, FERTIL STERIL, V94, P511, DOI 10.1016/j.fertnstert.2009.03.077
   Kowalska A., 2005, HIV AIDS REV, V4, P7
   LEE S, 2001, J BRASIL REPROD ASSI, V5, P64
   Liberati A, 2009, ANN INTERN MED, V151, pW65, DOI [10.1371/journal.pmed.1000100, 10.7326/0003-4819-151-4-200908180-00136]
   Manigart Y, 2006, HUM REPROD, V21, P2935, DOI 10.1093/humrep/del277
   Marina S, 1998, FERTIL STERIL, V70, P35, DOI 10.1016/S0015-0282(98)00102-2
   Marina S, 2002, GINECOL OBSTET CLIN, V3, P146
   Melo MAB, 2008, FERTIL STERIL, V89, P141, DOI 10.1016/j.fertnstert.2007.02.004
   Mencaglia L, 2005, HUM REPROD, V20, P2242, DOI 10.1093/humrep/dei031
   Nicopoullos JDM, 2004, FERTIL STERIL, V81, P670, DOI 10.1016/j.fertnstert.2003.08.019
   Pena JE, 2003, FERTIL STERIL, V80, P356, DOI 10.1016/S0015-0282(03)00662-9
   Prisant N, 2010, FERTIL STERIL, V93, P1020, DOI 10.1016/j.fertnstert.2009.07.1663
   Queiroz P, 2008, REV BRAS GINECOL OBS, V30, P171, DOI 10.1590/S0100-72032008000400003
   Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507
   Sauer MV, 2002, AM J OBSTET GYNECOL, V186, P627, DOI 10.1067/mob.2002.122125
   Savasi V, 2007, HUM REPROD, V22, P772, DOI 10.1093/humrep/del422
   SEMPRINI AE, 1992, LANCET, V340, P1317, DOI 10.1016/0140-6736(92)92495-2
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Tay Paul Y S, 2007, Med J Malaysia, V62, P286
   Terriou P, 2005, HUM REPROD, V20, P2838, DOI 10.1093/humrep/dei119
   van Leeuwen E, 2005, Ned Tijdschr Geneeskd, V149, P423
   Veiga A, 1999, PRENAT NEONAT MED, V4, P356
   World Health Organization United Nations International Children's Emergency Fund Joint United Nations Programme on HIV/AIDS, 2009, JOINT UN PROGR HIV A
   Zadehmodarres S, 2009, J ASSIST REPROD GEN, V26, P7, DOI 10.1007/s10815-008-9273-7
NR 36
TC 31
Z9 32
U1 0
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD APR
PY 2011
VL 95
IS 5
BP 1684
EP 1690
DI 10.1016/j.fertnstert.2011.01.127
PG 7
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 738OA
UT WOS:000288648000031
PM 21324449
DA 2020-11-24
ER

PT J
AU Hokerberg, YHM
   Aguiar, OB
   Reichenheim, M
   Faerstein, E
   Valente, JG
   Fonseca, MD
   Passos, SRL
AF Marques Hokerberg, Yara Hahr
   Aguiar, Odaleia Barbosa
   Reichenheim, Michael
   Faerstein, Eduardo
   Valente, Joaquim Goncalves
   Fonseca, Maria de Jesus
   Lambert Passos, Sonia Regina
TI Dimensional structure of the demand control support questionnaire: a
   Brazilian context
SO INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH
LA English
DT Article
DE Validation studies; Factor analysis; Stress, psychological; Demand
   control model
ID JOB CONTENT QUESTIONNAIRE; DECISION LATITUDE; PSYCHOMETRIC PROPERTIES;
   CARDIOVASCULAR-DISEASE; CULTURAL-ADAPTATION; CONSTRUCT-VALIDITY;
   JAPANESE VERSION; SOCIAL SUPPORT; FRENCH VERSION; CONTROL MODEL
AB According to Karasek, job strain results from an interaction between high demands and low decision latitude.
   To reassess the dimensional structure and evaluate the internal consistency of demand control support questionnaire (DCSQ), a shortened version of job content questionnaire that was not sufficiently evaluated in validation studies.
   The study investigated 825 workers who completed the DCSQ in Rio de Janeiro, Brazil; to 399 workers, the questionnaire was self-administered at a hospital (2004-2005), and 426 workers were interviewed at nine restaurants (2006-2007). Confirmatory factor analysis using structural equation models was used to test theoretical structure of dimensionality. Internal consistency was evaluated by composite reliability and convergent validity by average variance extracted.
   Confirmatory factor analysis supported the instrument in three dimensions: demands, skill discretion and decision authority. The best fit model was achieved by removing social support at work and the item repetitive work (skill discretion). A cross-loading from learning new things on demands and an error measurement correlation between work fast and work intense were confirmed. Composite reliability was acceptable for all dimensions, except for demands (0.58), which also showed inadequate average variance extracted (0.32). This final model was confirmed in separate analyses according to work setting, but the loadings of demands were lower for restaurant workers.
   Our results indicated that skill discretion and decision authority formed two distinct dimensions. Additionally, the item repetitive work should be removed, as well as one of the items work fast or work intense (demands). Future research is still required to confirm these findings.
C1 [Marques Hokerberg, Yara Hahr; Lambert Passos, Sonia Regina] Fundacao Oswaldo Cruz, Evandro Chagas Clin Res Inst, Clin Epidemiol Lab, BR-21040900 Rio De Janeiro, Brazil.
   [Marques Hokerberg, Yara Hahr; Aguiar, Odaleia Barbosa; Reichenheim, Michael; Faerstein, Eduardo; Valente, Joaquim Goncalves] Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil.
   [Aguiar, Odaleia Barbosa] Univ Estado Rio De Janeiro, Inst Nutr, Rio De Janeiro, Brazil.
   [Valente, Joaquim Goncalves; Fonseca, Maria de Jesus] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, BR-21040900 Rio De Janeiro, Brazil.
RP Hokerberg, YHM (corresponding author), Fundacao Oswaldo Cruz, Evandro Chagas Clin Res Inst, Clin Epidemiol Lab, Av Brasil,4365 Manguinhos, BR-21040900 Rio De Janeiro, Brazil.
EM yarahahr@ipec.fiocruz.br
RI Passos, Sonia/C-5292-2013
OI Passos, Sonia/0000-0001-9947-2291
CR Alves MGD, 2004, REV SAUDE PUBL, V38, P164, DOI 10.1590/s0034-89102004000200003
   Brisson C, 1998, WORK STRESS, V12, P322, DOI 10.1080/02678379808256870
   Brisson C, 2001, CAN J PUBLIC HEALTH, V92, P468, DOI 10.1007/BF03404542
   Brown T.A., 2006, CONFIRMATORY FACTOR
   Cheng YW, 2003, INT J BEHAV MED, V10, P15, DOI 10.1207/S15327558IJBM1001_02
   Choi BK, 2008, SCAND J WORK ENV HEA, P22
   de Araujo TM, 2008, SCAND J WORK ENV HEA, P52
   Edimansyah B. A., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P412
   Efron B., 1993, INTRO BOOTSTRAP
   Escriba-Aguir V, 2001, Gac Sanit, V15, P142
   Eum KD, 2007, INT ARCH OCC ENV HEA, V80, P497, DOI 10.1007/s00420-006-0156-x
   Ferrario M, 2005, Med Lav, V96, P191
   Ferrie JE, 2008, SCAND J WORK ENV HEA, P98
   Finney SJ, 2006, QUANT METH EDUC BEHA, P269
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Gagne P, 2006, MULTIVAR BEHAV RES, V41, P65, DOI 10.1207/s15327906mbr4101_5
   Hair J.F., 2006, MULTIVAR DATA ANAL, P770
   Herdman M, 1998, QUAL LIFE RES, V7, P323, DOI 10.1023/A:1024985930536
   Ibrahim SA, 2001, WOMEN HEALTH, V33, P105, DOI 10.1300/J013v33n01_07
   *ISCO, 1988, INT STAND CLASS OCC
   Johnson JV, 2008, SCAND J WORK ENV HEA, P15
   JOHNSON JV, 1988, AM J PUBLIC HEALTH, V78, P1336, DOI 10.2105/AJPH.78.10.1336
   KARASEK R, 1981, AM J PUBLIC HEALTH, V71, P694, DOI 10.2105/AJPH.71.7.694
   Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322
   Karasek R., 1990, HLTH WORK STRESS PRO
   KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498
   Karasek R, 2007, INT J BEHAV MED, V14, P189, DOI 10.1007/BF03002993
   Kawakami N, 1996, IND HEALTH, V34, P295, DOI 10.2486/indhealth.34.295
   Kawakami N, 1995, INT J BEHAV MED, V2, P358, DOI 10.1207/s15327558ijbm0204_5
   Kline R. B., 2005, PRINCIPLES PRACTICE
   Landsbergis P, 2000, OCCUP MED, V15, P163
   Li J, 2004, IND HEALTH, V42, P260, DOI 10.2486/indhealth.42.260
   Muthen B. O., 1998, MPLUS TECHNICAL APPE
   Muthen BO, 1993, TESTING STRUCTURAL E, P205, DOI DOI 10.1093/sf/73.3.1161
   Muthen LK, 1998, MPLUS USERS GUIDE
   Niedhammer I, 2002, INT ARCH OCC ENV HEA, V75, P129, DOI 10.1007/s004200100270
   NIEDHAMMER I, 2006, SANTE PUBLIQUE, V19, P413
   Pelfrene E, 2001, WORK STRESS, V15, P297, DOI 10.1080/02678370110086399
   Reichenheim ME, 2007, REV SAUDE PUBL, V41, P665, DOI 10.1590/S0034-89102006005000035
   Sale JEM, 2002, INT ARCH OCC ENV HEA, V75, P145, DOI 10.1007/s004200100289
   Sanne B, 2005, SCAND J PUBLIC HEALT, V33, P166, DOI 10.1080/14034940410019217
   SCHNALL PL, 1994, ANNU REV PUBL HEALTH, V15, P381, DOI 10.1146/annurev.pu.15.050194.002121
   Schreurs PJG, 1998, WORK STRESS, V12, P66, DOI 10.1080/02678379808256849
   Smith CS, 1997, J ORGAN BEHAV, V18, P225, DOI 10.1002/(SICI)1099-1379(199705)18:3<225::AID-JOB797>3.0.CO;2-E
   Stewart AL, 2000, MED CARE, V38, P102
   Tabanelli MC, 2008, INT ARCH OCC ENV HEA, V82, P1, DOI 10.1007/s00420-008-0312-6
   THEORELL T, 1988, SCAND J WORK ENV HEA, V14, P189, DOI 10.5271/sjweh.1932
   Theorell Tores, 1996, P69
   Van der Doef M, 1999, WORK STRESS, V13, P87, DOI 10.1080/026783799296084
NR 49
TC 25
Z9 27
U1 0
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0340-0131
EI 1432-1246
J9 INT ARCH OCC ENV HEA
JI Int. Arch. Occup. Environ. Health
PD APR
PY 2010
VL 83
IS 4
BP 407
EP 416
DI 10.1007/s00420-009-0488-4
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 567QI
UT WOS:000275461300006
PM 19941002
DA 2020-11-24
ER

PT J
AU de Souza, CTV
   Hokerberg, YHM
   Pacheco, SJB
   Rolla, VC
   Passos, SRL
AF Vieira de Souza, Claudia Teresa
   Marques Hoekerberg, Yara Hahr
   Bedoya Pacheco, Sandro Javier
   Rolla, Valeria Cavalcanti
   Lambert Passos, Sonia Regina
TI Effectiveness and safety of isoniazid chemoprophylaxis for HIV-1
   infected patients from Rio de Janeiro
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE tuberculosis; chemoprophylaxis; isoniazid; HIV-1; clinical trial
   (publication type); treatment outcome
ID HIV-INFECTED PATIENTS; LATENT TUBERCULOSIS INFECTION; CALMETTE-GUERIN
   VACCINATION; PREVENTIVE THERAPY; RISK-FACTORS; VIRUS-INFECTION;
   DRUG-USERS; METAANALYSIS; AFRICA
AB The clinical and epidemiological characteristics, adverse events, treatment adherence and effectiveness of isoniazid chemoprophylaxis were analyzed in a cohort of 138 tuberculosis/HIV-coinfected patients. An open, non-randomized, pragmatic prophylactic trial was conducted on adult patients with a normal chest X-ray and positive tuberculin skin test (>= 5 mm) who received isoniazid chemoprophylaxis (300 mg/day) for six months. The mean of follow up was 2.8 years (SD 1.3). Adherence to chemoprophylaxis was 87.7% (121/138). Only one patient presented tuberculosis after the end of chemoprophylaxis, corresponding to 0.3 cases per 100 persons per year. The relative risk of some adverse effects was 4.6 times higher (95% CI: 1.9-11.5) in patients with positive anti-HCV serology (4/9, 44.4%) compared to those with negative serology (12/129, 9.6%) (p = 0.002). This study provides evidence regarding the effectiveness and safety of a short and self-administered isoniazid regimen. We recommend the implementation of this routine by health service practitioners.
C1 [Vieira de Souza, Claudia Teresa; Marques Hoekerberg, Yara Hahr; Bedoya Pacheco, Sandro Javier; Lambert Passos, Sonia Regina] Fiocruz MS, Lab Epidemiol Clin, Inst Evandro Chagas, Fundacao Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [Rolla, Valeria Cavalcanti] Fiocruz MS, Lab Pesquisa Clin Micobacterioses, Inst Evandro Chagas, Fundacao Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
RP de Souza, CTV (corresponding author), Fiocruz MS, Lab Epidemiol Clin, Inst Evandro Chagas, Fundacao Oswaldo Cruz, Av Brasil 4-365, BR-21045900 Rio De Janeiro, Brazil.
EM clau@fiocruz.br
RI Passos, Sonia/C-5292-2013
OI Passos, Sonia/0000-0001-9947-2291
FU PAPES 3; Fiocruz; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); CRPHF
FX Financial support: PAPES 3, Fiocruz (2002/2003), FAPERJ (2004/2005),
   CRPHF (2004)
CR [Anonymous], 2007, GLOB TUB CONTR SURV
   Blumberg HM, 2005, JAMA-J AM MED ASSOC, V293, P2776, DOI 10.1001/jama.293.22.2776
   Bucher HC, 1999, AIDS, V13, P501, DOI 10.1097/00002030-199903110-00009
   Casado JL, 2002, CLIN INFECT DIS, V34, P386, DOI 10.1086/324746
   *CDCP AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, pS221
   Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P735
   Churchyard GJ, 2003, AIDS, V17, P2063, DOI 10.1097/00002030-200309260-00007
   de Pinho AMF, 2001, AIDS, V15, P2129, DOI 10.1097/00002030-200111090-00008
   Elzi L, 2007, CLIN INFECT DIS, V44, P1016
   Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441
   Gourevitch MN, 1999, AIDS, V13, P2069, DOI 10.1097/00002030-199910220-00009
   Grant AD, 2005, JAMA-J AM MED ASSOC, V293, P2719, DOI 10.1001/jama.293.22.2719
   Hiransuthikul N, 2005, INT J TUBERC LUNG D, V9, P270
   Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1
   Last J., 2001, DICT EPIDEMIOLOGY
   Lienhardt C, 2003, AM J RESP CRIT CARE, V168, P448, DOI 10.1164/rccm.200212-1483OC
   Moulton LH, 2007, CLIN TRIALS, V4, P190, DOI 10.1177/1740774507076937
   *MS, 2007, REC TER ANT AD AD IN
   Neuenschwander BE, 2002, AM J EPIDEMIOL, V155, P654, DOI 10.1093/aje/155.7.654
   Rivero A, 2007, ENFERM INFEC MICR CL, V25, P305, DOI 10.1157/13102265
   Sadaphal P, 2001, CLIN INFECT DIS, V33, P1687, DOI 10.1086/323896
   San Sebastian M, 2000, RESP MED, V94, P648, DOI 10.1053/rmed.1999.0877
   Santoro-Lopes G, 2002, CLIN INFECT DIS, V34, P543, DOI 10.1086/338641
   Szakacs TA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-97
   Tissot F, 2005, CLIN INFECT DIS, V40, P211, DOI 10.1086/426434
   Toledo ACD, 2000, MEM I OSWALDO CRUZ, V95, P437, DOI 10.1590/S0074-02762000000400001
   Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2
   Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804
   Whalen CC, 2005, JAMA-J AM MED ASSOC, V293, P2785, DOI 10.1001/jama.293.22.2785
   Woldehanna S, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000171.pub2, DOI 10.1002/14651858.CD000171.PUB2]
NR 30
TC 15
Z9 16
U1 0
U2 2
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAY
PY 2009
VL 104
IS 3
BP 462
EP 467
DI 10.1590/S0074-02762009000300011
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 462EX
UT WOS:000267332000011
PM 19547873
OA DOAJ Gold
DA 2020-11-24
ER

PT J
AU Passos, SRL
   Bedoya, SJ
   Hokerberg, YHM
   Maia, SC
   Georg, I
   Nogueira, RMR
   Souza, RV
   Marzochi, KBF
AF Passos, S. R. L.
   Bedoya, S. J.
   Hoekerberg, Y. H. M.
   Maia, S. C.
   Georg, I.
   Nogueira, R. M. R.
   Souza, R. V.
   Marzochi, K. B. F.
TI Clinical and Laboratory Signs as Dengue Markers During an Outbreak in
   Rio de Janeiro
SO INFECTION
LA English
DT Article
ID HEMORRHAGIC-FEVER; BRAZIL; SURVEILLANCE; INFECTION; EPIDEMIC;
   CIRCULATION
AB One of the main challenges for clinical research in dengue is the low validity of clinical diagnosis.
   To analyze clinical and laboratory data as predicitve factors of dengue diagnosis at Evandro Chagas Clinical Research Institute, Oswaldo Cruz Foundation, during the 2001-2002 dengue outbreak in Rio de Janeiro.
   Cross sectional study comparing clinical laboratory data collected from the National Information System for Compulsory Notification Diseases (SINAN) in two serologically confirmed groups: dengue D (N = 453) and non-dengue ND (N = 80).
   Fever, exanthema, itching, mean platelet count < 150,000, WBC count < 4,000 and absence of vomiting and of abdominal pain help to distinguish D from ND groups. When considered individually, these signs and symptoms enhance diagnostic sensitivity and, when used in combination, improve specificity.
   A combination of symptoms not necessarily considered indicative of dengue diagnosis could improve surveillance and medical decision-making in simple clinical settings.
C1 [Passos, S. R. L.; Bedoya, S. J.; Hoekerberg, Y. H. M.; Maia, S. C.; Georg, I.; Nogueira, R. M. R.; Souza, R. V.; Marzochi, K. B. F.] Evandro Chagas Clin Res Inst, Clin Epidemiol Lab, BR-21045900 Rio De Janeiro, Brazil.
RP Passos, SRL (corresponding author), Evandro Chagas Clin Res Inst, Clin Epidemiol Lab, Av Brasil 4365 Manguinhos, BR-21045900 Rio De Janeiro, Brazil.
EM sonialambert@ipec.fiocruz.br
RI Passos, Sonia/C-5292-2013
OI Passos, Sonia/0000-0001-9947-2291
FU Oswaldo Cruz Foundation [RDCL05]
FX This work was supported by grants from the Oswaldo Cruz Foundation (
   PDTSP, number RDCL05).
CR Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x
   Barbosa da Silva Jarbas Jr, 2002, Epidemiol Bull, V23, P3
   Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41
   BRASIL MS, 2002, GUIA VIGILANCIA EPID, P201
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Casali Clarisse Guimarães, 2004, Rev. Soc. Bras. Med. Trop., V37, P296, DOI 10.1590/S0037-86822004000400002
   De Simone TS, 2004, T ROY SOC TROP MED H, V98, P553, DOI 10.1016/j.trstmh.2003.09.003
   Díaz Fredi Alexander, 2006, Biomédica, V26, P22
   DIETZ VJ, 1990, AM J EPIDEMIOL, V131, P693
   Gibbons RV, 2002, BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   Phuong HL, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-123
   Hudson CP, 1997, INT J STD AIDS, V8, P393, DOI 10.1258/0956462971920325
   Kuno Goro, 2003, Adv Virus Res, V61, P3, DOI 10.1016/S0065-3527(03)61001-8
   Low JGH, 2006, ANN ACAD MED SINGAP, V35, P783
   MARTINEZ RA, 2004, BIOMEDICA, V25, P412
   Martinez-Vega RA, 2006, REV MED CHILE, V134, P1153, DOI 10.4067/S0034-98872006000900010
   MARZOCHI KBF, 2004, REV SOC BRAS MED TRO, V375, P413
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   Nunes-Araujo FRF, 2003, ANN TROP MED PARASIT, V97, P415, DOI 10.1179/000349803235002263
   Passos Maíla Naves Pereira, 2004, Rev. Soc. Bras. Med. Trop., V37, P293, DOI 10.1590/S0037-86822004000400001
   Siqueira JB, 2004, AM J TROP MED HYG, V71, P646, DOI 10.4269/ajtmh.2004.71.646
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Telles EE, 2002, ETHNIC RACIAL STUD, V25, P415, DOI 10.1080/01419870252932133
   Torres EM, 2006, REV PANAM SALUD PUBL, V20, P60, DOI 10.1590/S1020-49892006000700013
   Travassos Claudia, 2004, Cad. Saúde Pública, V20, P660, DOI 10.1590/S0102-311X2004000300003
   Vasconcelos PFC, 1998, REV SAUDE PUBL, V32, P447, DOI 10.1590/S0034-89101998000500007
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 30
TC 8
Z9 10
U1 0
U2 1
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0300-8126
EI 1439-0973
J9 INFECTION
JI Infection
PD DEC
PY 2008
VL 36
IS 6
BP 570
EP 574
DI 10.1007/s15010-008-7334-6
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA 397YI
UT WOS:000262697900011
PM 19020803
DA 2020-11-24
ER

EF